Gefitinib (ZD1839)

目录号：S1025

Molecular Weight(MW): 446.90

Gefitinib (ZD1839)是一种EGFR抑制剂，作用于NR6wtEGFR和NR6W细胞中的Tyr1173，Tyr992，Tyr1173和Tyr992，IC50 分别为37 nM，37nM，26 nM和57 nM。

规格

价格

库存

购买数量

10mM/1mL In DMSO	RMB 1574.78	现货
100mg	RMB 1227.69	现货
250mg	RMB 2205.98	现货
大包装	有超大折扣

大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck该产品发表文献283篇：

Cancer Discov, 2019, 9(7):926-943

PubMed: 31092401 ( click the link to review the publication )

Cell Stem Cell, 2019, 25(1):69-86

PubMed: 31080136 ( click the link to review the publication )

Cell, 2018, 172(1-2):373-386

PubMed: 29224780 ( click the link to review the publication )

Nat Med, 2018, 24(4):512-517

PubMed: 29505033 ( click the link to review the publication )

Nat Methods, 2018, 15(8):631-639

PubMed: 30038414 ( click the link to review the publication )

Cancer Cell, 2018, 34(3):427-438

PubMed: 30205045 ( click the link to review the publication )

Nature, 2017, 547(7664):453-457

PubMed: 28678785 ( click the link to review the publication )

Nature, 2016, 534(7609):647-51

PubMed: 27338794 ( click the link to review the publication )

Nat Med, 2016, 22(3):262-9

PubMed: 26828195 ( click the link to review the publication )

Cancer Discov, 2015, 5(7):713-22

PubMed: 25934077 ( click the link to review the publication )

Cancer Discov, 2015, 5(9):960-971

PubMed: 26036643 ( click the link to review the publication )

Nature, 2014, 508(7494):118-22

PubMed: 24670642 ( click the link to review the publication )

Nat Med, 2013, 19(11):1469-1472

PubMed: 24162815 ( click the link to review the publication )

Nature, 2012, 483(7387):100-3

PubMed: 22281684 ( click the link to review the publication )

Cell, 2012, 151(5):937-50

PubMed: 23178117 ( click the link to review the publication )

Cancer Discov, 2012, 2(10):934-47

PubMed: 22961667 ( click the link to review the publication )

Cancer Discov, 2011, 1(7):608-25

PubMed: 22586683 ( click the link to review the publication )

Nat Cell Biol, 2019, 21(6):778-790

PubMed: 31160710 ( click the link to review the publication )

Mol Cell, 2019, 73(1):166-182

PubMed: 30609389 ( click the link to review the publication )

Hepatology, 2019, 10.1002/hep.30780

PubMed: 31127639 ( click the link to review the publication )

Nat Commun, 2019, 10(1):2701

PubMed: 31221965 ( click the link to review the publication )

Nano Lett, 2019, 19(10):7526-7533

PubMed: 31487192 ( click the link to review the publication )

Nat Commun, 2019, 10(1):2919

PubMed: 31266962 ( click the link to review the publication )

Autophagy, 2019, 10.1080/15548627.2019.1660545

PubMed: 31462148 ( click the link to review the publication )
Autophagy, 2019, 10.1080/15548627.2019.1660545

PubMed: 31462148 ( click the link to review the publication )

EMBO J, 2019, 38(4)

PubMed: 30643021 ( click the link to review the publication )

Cancer Res, 2019, 79(4):819-829

PubMed: 30573522 ( click the link to review the publication )

J Am Soc Nephrol, 2019, 30(8):1454-1470

PubMed: 31253651 ( click the link to review the publication )

Matrix Biol, 2019, 10.1016/j.matbio.2019.07.006

PubMed: 31323325 ( click the link to review the publication )

Cell Rep, 2019, 26(1):65-78

PubMed: 30605687 ( click the link to review the publication )

Int J Cancer, 2019, 10.1002/ijc.32487

PubMed: 31162839 ( click the link to review the publication )

Int J Cancer, 2019, 145(5):1432-1444

PubMed: 30784054 ( click the link to review the publication )

Oncogene, 2019, 38(11):1936-1950

PubMed: 30390071 ( click the link to review the publication )

Oncogene, 2019, 38(37):6399-6413

PubMed: 31324888 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):46

PubMed: 30709379 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):96

PubMed: 30791926 ( click the link to review the publication )

J Exp Clin Cancer Res, 2019, 38(1):481

PubMed: 31801598 ( click the link to review the publication )

Cancers (Basel), 2019, 11(1)

PubMed: 30609749 ( click the link to review the publication )

Cancers (Basel), 2019, 11(10)

PubMed: 31635301 ( click the link to review the publication )

Breast Cancer Res, 2019, 21(1):77

PubMed: 31262335 ( click the link to review the publication )

Cell Death Dis, 2019, 10(4):283

PubMed: 30911072 ( click the link to review the publication )

Signal Transduct Target Ther, 2019, 4:25

PubMed: 31637005 ( click the link to review the publication )

Cells, 2019, 8(12)

PubMed: 31795298 ( click the link to review the publication )

Cell Physiol Biochem, 2019, 53(5):805-819

PubMed: 31670920 ( click the link to review the publication )

Mol Cancer Ther, 2019, 10.1158/1535-7163.MCT-19-0181

PubMed: 31501278 ( click the link to review the publication )

Cell Prolif, 2019, 52(6):e12680

PubMed: 31454111 ( click the link to review the publication )

Neoplasia, 2019, 22(1):1-9

PubMed: 31751859 ( click the link to review the publication )

Lung Cancer, 2019, 137:85-93

PubMed: 31563735 ( click the link to review the publication )
Cancer Biol Med, 2019, 16(3):606-617

PubMed: 31565489 ( click the link to review the publication )

Artif Cells Nanomed Biotechnol, 2019, 47(1):3231-3238

PubMed: 31373232 ( click the link to review the publication )

DNA Repair (Amst), 2019, 78:37-44

PubMed: 30954901 ( click the link to review the publication )

Front Oncol, 2019, 9:1167

PubMed: 31750252 ( click the link to review the publication )

Cancer Sci, 2019, 110(11):3584-3594

PubMed: 31446643 ( click the link to review the publication )

Biochem Pharmacol, 2019, 169:113640

PubMed: 31536726 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(19)

PubMed: 31546690 ( click the link to review the publication )

J Biol Chem, 2019, 294(12):4488-4497

PubMed: 30679314 ( click the link to review the publication )

Mol Pharmacol, 2019, 95(5):528-536

PubMed: 30858165 ( click the link to review the publication )

Cancer Cell Int, 2019, 19:117

PubMed: 31073278 ( click the link to review the publication )

Mol Carcinog, 2019, 10.1002/mc.23139

PubMed: 31777985 ( click the link to review the publication )

Front Pharmacol, 2019, 10:1116

PubMed: 31649529 ( click the link to review the publication )

Respir Res, 2019, 20(1-:270

PubMed: 31791326 ( click the link to review the publication )

Respir Res, 2019, 20(1):164

PubMed: 31331328 ( click the link to review the publication )

Biomed Pharmacother, 2019, 118:109169

PubMed: 31310954 ( click the link to review the publication )

J Proteomics, 2019, 195:114-124

PubMed: 30660770 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(10)

PubMed: 31121829 ( click the link to review the publication )

Int J Oncol, 2019, 54(2):527-536

PubMed: 30535494 ( click the link to review the publication )

Life Sci, 2019, 224:23-32

PubMed: 30902544 ( click the link to review the publication )

J Drug Target, 2019, 27(4):451-459

PubMed: 30381967 ( click the link to review the publication )

Int J Biochem Cell Biol, 2019, 106:96-106

PubMed: 30471423 ( click the link to review the publication )

Molecules, 2019, 24(3)

PubMed: 30754629 ( click the link to review the publication )

Transl Oncol, 2019, 12(11):1516-1524

PubMed: 31450127 ( click the link to review the publication )

Eur J Pharmacol, 2019, 855:10-19

PubMed: 31028739 ( click the link to review the publication )
Eur J Pharmacol, 2019, 850:97-108

PubMed: 30753867 ( click the link to review the publication )

Eur J Pharmacol, 2019, 856:172409

PubMed: 31132355 ( click the link to review the publication )

Biosci Rep, 2019, 39(8)

PubMed: 31316001 ( click the link to review the publication )

Onco Targets Ther, 2019, 12:6033-6043

PubMed: 31440060 ( click the link to review the publication )

Biomed Res Int, 2019, 2019:3129748

PubMed: 31346515 ( click the link to review the publication )

Oncol Lett, 2019, 18(5):5621-5627

PubMed: 31620204 ( click the link to review the publication )

Oncol Lett, 2019, 18(1):368-374

PubMed: 31289508 ( click the link to review the publication )

Anticancer Res, 2019, 39(7):3785-3793

PubMed: 31262905 ( click the link to review the publication )

Exp Ther Med, 2019, 17(1):953-959

PubMed: 30651886 ( click the link to review the publication )

Oncotarget, 2019, 10(11):1171-1192

PubMed: 30838090 ( click the link to review the publication )

JCI Insight, 2019, 4(21)

PubMed: 31600169 ( click the link to review the publication )

Oncotarget, 2019, 10(26):2546-2560

PubMed: 31069016 ( click the link to review the publication )

Nat Biomed Eng, 2018, 2(4):239-253

PubMed: 30936439 ( click the link to review the publication )

Nat Commun, 2018, 9(1):4728

PubMed: 30413706 ( click the link to review the publication )

Nat Commun, 2018, 9(1):2434

PubMed: 29934552 ( click the link to review the publication )

EMBO Mol Med, 2018, 10(3)

PubMed: 29449326 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(13):3097-3107

PubMed: 29506987 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(16):3928-3940

PubMed: 29685880 ( click the link to review the publication )

Theranostics, 2018, 8(5):1256-1269

PubMed: 29507618 ( click the link to review the publication )

J Control Release, 2018, 275:117-128

PubMed: 29474960 ( click the link to review the publication )

J Hematol Oncol, 2018, 11(1):109

PubMed: 30157900 ( click the link to review the publication )

Oncogene, 2018, 37(12):1576-1593

PubMed: 29326440 ( click the link to review the publication )

Cancer Lett, 2018, 424:84-96

PubMed: 29524558 ( click the link to review the publication )

Sci Signal, 2018, 11(549)

PubMed: 30254057 ( click the link to review the publication )
Cancers (Basel), 2018, 10(6)

PubMed: 29925812 ( click the link to review the publication )

FASEB J, 2018, 10.1096/fj.201800011R

PubMed: 29812969 ( click the link to review the publication )

Exp Mol Med, 2018, 50(1):e435

PubMed: 29371698 ( click the link to review the publication )

Exp Mol Med, 2018, 50(4):52

PubMed: 29700289 ( click the link to review the publication )

Cell Physiol Biochem, 2018, 51(1):337-355

PubMed: 30453282 ( click the link to review the publication )

Cell Commun Signal, 2018, 16(1):77

PubMed: 30409180 ( click the link to review the publication )

Mol Cell Proteomics, 2018, 17(10):1892-1908

PubMed: 29970458 ( click the link to review the publication )

Eur J Med Chem, 2018, 144:330-348

PubMed: 29275232 ( click the link to review the publication )

Oncogenesis, 2018, 7(9):67

PubMed: 30190455 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(3):543-553

PubMed: 29222171 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(10):1458-1469

PubMed: 29934325 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(11):1773-1784

PubMed: 29967110 ( click the link to review the publication )

Mol Cancer Res, 2018, 16(7):1185-1195

PubMed: 29724813 ( click the link to review the publication )

J Immunol, 2018, 200(8):2809-2818

PubMed: 29531172 ( click the link to review the publication )

Biochem Pharmacol, 2018, 152:327-337

PubMed: 29660315 ( click the link to review the publication )

Sci Rep, 2018, 8(1):18043

PubMed: 30575780 ( click the link to review the publication )

J Biol Chem, 2018, 293(35):13401-13414

PubMed: 29997256 ( click the link to review the publication )

Respir Res, 2018, 19(1):96

PubMed: 29784046 ( click the link to review the publication )

Cancer Manag Res, 2018, 10:5785-5798

PubMed: 30510448 ( click the link to review the publication )

Cancer Manag Res, 2018, 10:6695-6703

PubMed: 30584364 ( click the link to review the publication )

Cancer Commun (Lond), 2018, 38(1):50

PubMed: 30053908 ( click the link to review the publication )

Phytomedicine, 2018, 39:33-41

PubMed: 29433681 ( click the link to review the publication )

Int J Oncol, 2018, 52(6):2143-2154

PubMed: 29620166 ( click the link to review the publication )

Invest New Drugs, 2018, 36(6):999-1005

PubMed: 29594878 ( click the link to review the publication )
Cancer Biol Ther, 2018, 19(10):921-933

PubMed: 29856687 ( click the link to review the publication )

Cell Cycle, 2018, 17(23):2577-2592

PubMed: 30488756 ( click the link to review the publication )

Transl Oncol, 2018, 11(6):1406-1418

PubMed: 30219696 ( click the link to review the publication )

Oncol Rep, 2018, 40(4):2171-2182

PubMed: 30106444 ( click the link to review the publication )

Oncol Rep, 2018, 40(4):1937-1946

PubMed: 30106446 ( click the link to review the publication )

Oncol Rep, 2018, 40(2):775-782

PubMed: 29901173 ( click the link to review the publication )

Onco Targets Ther, 2018, 11:8455-8463

PubMed: 30555238 ( click the link to review the publication )

J Ovarian Res, 2018, 11(1):12

PubMed: 29402301 ( click the link to review the publication )

Mol Med Rep, 2018, 18(4):3882-3890

PubMed: 30106133 ( click the link to review the publication )

Oncol Lett, 2018, 15(3):2829-2838

PubMed: 29467862 ( click the link to review the publication )

Oncotarget, 2018, 9(51):29680-29697

PubMed: 30038713 ( click the link to review the publication )

Oncotarget, 2018, 9(26):18254-18268

PubMed: 29719603 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2018, 115(42):E9869-E9878

PubMed: 30275324 ( click the link to review the publication )

Nat Commun, 2017, 8(1):410

PubMed: 28871105 ( click the link to review the publication )

Autophagy, 2017, 13(7):1093-1112

PubMed: 28513279 ( click the link to review the publication )

Proc Natl Acad Sci U S A, 2017, 114(15):E3129-E3138

PubMed: 28351972 ( click the link to review the publication )

Genes Dev, 2017, 31(17):1754-1769

PubMed: 28982759 ( click the link to review the publication )

Cancer Res, 2017, 77(13):3551-3563

PubMed: 28428274 ( click the link to review the publication )

Cell Rep, 2017, 21(11):3298-3309

PubMed: 29241554 ( click the link to review the publication )

Mol Cancer, 2017, 16(1):34

PubMed: 28158983 ( click the link to review the publication )

Int J Cancer, 2017, 141(9):1921-1931

PubMed: 28710768 ( click the link to review the publication )

ACS Photonics, 2017, 5(2):487-494

PubMed: 29805987 ( click the link to review the publication )

Oncogene, 2017, 36(48):6691-6700

PubMed: 28745317 ( click the link to review the publication )

J Med Chem, 2017, 60(17):7447-7458

PubMed: 28787156 ( click the link to review the publication )
Transl Lung Cancer Res, 2017, 6(5):600-610

PubMed: 29114475 ( click the link to review the publication )

Acta Pharmacol Sin, 2017, 38(11):1501-1511

PubMed: 29022575 ( click the link to review the publication )

Oncol Rep, 2017, 38(4):2205-2210

PubMed: 28791365 ( click the link to review the publication )

Eur J Pharmacol, 2017, 821:21-28

PubMed: 29277715 ( click the link to review the publication )

Oncol Rep, 2017, 37(2):1212-1218

PubMed: 27959426 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 493(1):213-219

PubMed: 28899783 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 482(4):1334-1340

PubMed: 27939888 ( click the link to review the publication )

Biochem Biophys Res Commun, 2017, 486(4):1027-1033

PubMed: 28366635 ( click the link to review the publication )

Oncol Lett, 2017, 14(4):4349-4354

PubMed: 28959367 ( click the link to review the publication )

Oncotarget, 2017, 8(3):4277-4288

PubMed: 28032592 ( click the link to review the publication )

Oncotarget, 2017, 8(14):22414-22432

PubMed: 26461472 ( click the link to review the publication )

Oncotarget, 2017, 8(70):115620-115631

PubMed: 29383186 ( click the link to review the publication )

Oncotarget, 2017, 8(29):47305-47316

PubMed: 28521301 ( click the link to review the publication )

Oncotarget, 2017, 8(35):58771-58780

PubMed: 28938595 ( click the link to review the publication )

Hepatology, 2016, 64(2):488-500

PubMed: 27015352 ( click the link to review the publication )

Genome Biol, 2016, 17:80

PubMed: 27139883 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

J Clin Invest, 2016, 126(9):3296-312

PubMed: 27482886 ( click the link to review the publication )

Nat Commun, 2016, 7:12231

PubMed: 27456471 ( click the link to review the publication )

Clin Cancer Res, 2016, 22(21):5370-5382

PubMed: 27178741 ( click the link to review the publication )

EMBO Rep, 2016, 17(5):724-38

PubMed: 27013495 ( click the link to review the publication )

J Pathol, 2016, 239(3):320-34

PubMed: 27102572 ( click the link to review the publication )

Acta Neuropathol Commun, 2016, 4(1):96

PubMed: 27586084 ( click the link to review the publication )

Mol Cancer Ther, 2016, 10.1158/1535-7163.MCT-15-0375

PubMed: 27196768 ( click the link to review the publication )
Oral Oncol, 2016, 59:12-19

PubMed: 27424178 ( click the link to review the publication )

Oral Oncol, 2016, 56:62-70

PubMed: 27086488 ( click the link to review the publication )

Biochim Biophys Acta, 2016, 10.1016/j.bbagen.2016.05.011

PubMed: 27180173 ( click the link to review the publication )

Biochim Biophys Acta, 2016, 1859(11):1449-1458

PubMed: 27412911 ( click the link to review the publication )

Clin Lung Cancer, 2016, 17(4):263-270

PubMed: 26707383 ( click the link to review the publication )

J Proteome Res, 2016, 15(12):4490-4504

PubMed: 27794612 ( click the link to review the publication )

Int J Oncol, 2016, 49(4):1427-36

PubMed: 27498706 ( click the link to review the publication )

Int J Oncol, 2016, 48(3):937-44

PubMed: 26783187 ( click the link to review the publication )

Exp Cell Res, 2016, 344(2):194-200

PubMed: 27180268 ( click the link to review the publication )

Eur J Pharmacol, 2016, 789:458-467

PubMed: 27514773 ( click the link to review the publication )

Oncol Rep, 2016, 36(2):729-36

PubMed: 27373987 ( click the link to review the publication )

Neurosurg Focus, 2016, 41(6):E14

PubMed: 27903123 ( click the link to review the publication )

PLoS One, 2016, 11(5):e0155230

PubMed: 27153109 ( click the link to review the publication )

PLoS One, 2016, 11(9):e0163149

PubMed: 27643613 ( click the link to review the publication )

Oncotarget, 2016, 7(4):3847-56

PubMed: 26716903 ( click the link to review the publication )

Oncotarget, 2016, 7(18-:25983-6002

PubMed: 27036020 ( click the link to review the publication )

Oncotarget, 2016, 7(32):52392-52403

PubMed: 27447558 ( click the link to review the publication )

Cell Res, 2015, 10.1038/cr.2015.16

PubMed: 25656847 ( click the link to review the publication )

Nat Commun, 2015, 6:6377

PubMed: 25758528 ( click the link to review the publication )

Nat Commun, 2015, 6:6240

PubMed: 25670642 ( click the link to review the publication )

J Thorac Oncol, 2015, 10.1097/JTO.0000000000000500

PubMed: 25658629 ( click the link to review the publication )

Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-14-2789

PubMed: 25948633 ( click the link to review the publication )

Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-15-0560

PubMed: 25964297 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2015, 112(6):1839-44

PubMed: 25605917 ( click the link to review the publication )
Cell Rep, 2015, 10.1016/j.celrep.2015.04.049

PubMed: 26027934 ( click the link to review the publication )

Cancer Lett, 2015, 369(1):103-11

PubMed: 26297988 ( click the link to review the publication )

Mol Cancer Ther, 2015, 14(10-:2238-48

PubMed: 26208525 ( click the link to review the publication )

Mol Oncol, 2015, 9(2):527-43

PubMed: 25454348 ( click the link to review the publication )

Mol Cell Proteomics, 2015, 10.1074/mcp.M115.049783 mcp.M115.049783.

PubMed: 25953087 ( click the link to review the publication )

Lung Cancer, 2015, 88(1):16-23

PubMed: 25704955 ( click the link to review the publication )

J Biol Chem, 2015, 290(41):24784-92

PubMed: 26304118 ( click the link to review the publication )

J Chromatogr A, 2015, 10.1016/j.chroma.2015.04.055

PubMed: ( click the link to review the publication )

Toxicol Appl Pharmacol, 2015, 10.1016/j.taap.2015.05.001

PubMed: 25981168 ( click the link to review the publication )

Int J Oncol, 2015, 46(3):1214-24

PubMed: 25530180 ( click the link to review the publication )

Oncol Rep, 2015, 33(4):1860-6

PubMed: 25634113 ( click the link to review the publication )

Oncol Rep, 2015, 34(3):1613-9

PubMed: 26166014 ( click the link to review the publication )

Oncol Rep, 2015, 34(4):1875-82

PubMed: 26238612 ( click the link to review the publication )

Pathol Oncol Res, 2015, 10.1007/s12253-015-9916-9

PubMed: 25749811 ( click the link to review the publication )

Anticancer Res, 2015, 35(5):2795-803

PubMed: 25964559 ( click the link to review the publication )

Int J Radiat Oncol Biol Phys, 2015, 10.1016/j.ijrobp.2015.01.026

PubMed: 25823448 ( click the link to review the publication )

Sci Transl Med, 2014, 6(219):219ra9

PubMed: 24431113 ( click the link to review the publication )

Mol Cell, 2014, 55(6):904-15

PubMed: 25219500 ( click the link to review the publication )

Cancer Res, 2014, 74(1):253-62

PubMed: 24165158 ( click the link to review the publication )

Elife, 2014, 3:e02523

PubMed: 24844246 ( click the link to review the publication )

Int J Cancer, 2014, 134(11):2560-71

PubMed: 24374738 ( click the link to review the publication )

Oncogene, 2014, 33(19):2495-503

PubMed: 23728339 ( click the link to review the publication )

Oncogene, 2014, 33(35):4385-95

PubMed: 24096476 ( click the link to review the publication )

MBio, 2014, 5(4):e01340-14

PubMed: 25096879 ( click the link to review the publication )
Cancer Lett, 2014, 342(1):82-91

PubMed: 24001610 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1445

PubMed: 25299770 ( click the link to review the publication )

Mol Oncol, 2014, 10.1016/j.molonc.2014.05.005

PubMed: 24908424 ( click the link to review the publication )

Mol Oncol, 2014, 9(1):260-9

PubMed: 25226813 ( click the link to review the publication )

Cell Oncol , 2014, 37(5):377-86

PubMed: 25228008 ( click the link to review the publication )

Lung Cancer, 2014, 85(2):141-6

PubMed: 24957682 ( click the link to review the publication )

Antimicrob Agents Chemother, 2014, 10.1128/AAC.02393-14

PubMed: 24663025 ( click the link to review the publication )

Colloids and Surfaces B: Biointerfaces, 2014, 123:61-7

PubMed: 25216919 ( click the link to review the publication )

Drug Metab Dispos, 2014, 42(3):318-22

PubMed: 24335466 ( click the link to review the publication )

Drug Metab Dispos, 2014, 42(11):1851-7

PubMed: 25165131 ( click the link to review the publication )

Int J Oncol, 2014, 45(1):393-400

PubMed: 24819550 ( click the link to review the publication )

Cell Cycle, 2014, 13(24):3808-17

PubMed: ( click the link to review the publication )

Am J Physiol Renal Physiol, 2014, 307(4):F435-44

PubMed: 24990892 ( click the link to review the publication )

Cancer Chemoth Pharm, 2014, 74(3):511-20

PubMed: 25038613 ( click the link to review the publication )

PLoS One, 2014, 9(4):e93651

PubMed: 24695557 ( click the link to review the publication )

PLoS One, 2014, 9(4):e95243

PubMed: 24743578 ( click the link to review the publication )

PLoS One, 2014, 9(12):e114000

PubMed: 25486409 ( click the link to review the publication )

PLoS One, 2014, 9(5):e97719

PubMed: 24874286 ( click the link to review the publication )

Horm Cancer, 2014, 289(24):17195-202

PubMed: 24778185 ( click the link to review the publication )

Exp Mol Pathol, 2014, 97(1):154-165

PubMed: 24984270 ( click the link to review the publication )

Langenbecks Arch Surg, 2014, 10.1007/s00423-014-1235-1

PubMed: 25070024 ( click the link to review the publication )

Korean J Parasitol, 2014, 52(4):439-41

PubMed: 25246725 ( click the link to review the publication )

Int J Radiat Oncol Biol Phys, 2014, 88(4):947-54

PubMed: 24606853 ( click the link to review the publication )

University of Alberta, 2014, Yahya Muhammad Fiteih

PubMed: ( click the link to review the publication )
Guangxi Medical University, 2014, Suning Huang

PubMed: ( click the link to review the publication )

JBUON , 2014, 19(2): 466-473

PubMed: ( click the link to review the publication )

Ann Oncol, 2013, 24(2):362-9

PubMed: 22967992 ( click the link to review the publication )

J Clin Endocrinol Metab, 2013, 98(6):2502-12

PubMed: 23559083 ( click the link to review the publication )

Mol Cancer Ther, 2013, 13(2):444-53

PubMed: 24258346 ( click the link to review the publication )

Mol Cancer Ther, 2013, 12(11):2541-58

PubMed: 24026012 ( click the link to review the publication )

Mol Oncol, 2013, 7(1):121-9

PubMed: 23127547 ( click the link to review the publication )

Carcinogenesis, 2013, 34(9):1994-9

PubMed: 23677069 ( click the link to review the publication )

Cell Prolif, 2013, 46(4):447-56

PubMed: 23829318 ( click the link to review the publication )

Radiother Oncol, 2013, 108(3):473-8

PubMed: 23891090 ( click the link to review the publication )

J Biol Chem, 2013, 288(48):34930-42

PubMed: 24142702 ( click the link to review the publication )

Drug Metab Dispos, 2013, 10.1124/dmd.113.054189

PubMed: 24335466 ( click the link to review the publication )

Prostate, 2013, 73(13):1453-61

PubMed: 23765757 ( click the link to review the publication )

PLoS One, 2013, 8(12):e81393

PubMed: 24339922 ( click the link to review the publication )

PLoS One, 2013, 8(12):e82625

PubMed: 24349321 ( click the link to review the publication )

Exp Mol Pathol, 2013, 94(2):386-97

PubMed: 23399805 ( click the link to review the publication )

Evid Based Complement Alternat Med, 2013, 2013:243859

PubMed: 23533466 ( click the link to review the publication )

J Genet Syndr Gene Ther, 2013, 4

PubMed: 25520884 ( click the link to review the publication )

Herpesviridae, 2013, 4(1):1

PubMed: 23342981 ( click the link to review the publication )

Oncotarget, 2013, 4(10):1698-1711

PubMed: 24091605 ( click the link to review the publication )

Tuberc Respir Dis, 2013, 75(3):95-103

PubMed: 24101933 ( click the link to review the publication )

Cell Death Differ, 2012, 19(12):1908-16

PubMed: 22722337 ( click the link to review the publication )

Int J Cancer, 2012, 131(12):2961-9

PubMed: 22514082 ( click the link to review the publication )

Int J Cancer, 2012, 131(2):334-43

PubMed: 21858806 ( click the link to review the publication )
Oncogene, 2012, 32(34):4034-42

PubMed: 22964644 ( click the link to review the publication )

Cancer Lett, 2012, 321(2):187-94

PubMed: 22343320 ( click the link to review the publication )

Cancer Sci, 2012, 103(1):7-16

PubMed: 21951556 ( click the link to review the publication )

Biochem Pharmacol, 2012, 84(4):425-31

PubMed: 22634404 ( click the link to review the publication )

Int J Mol Sci, 2012, 13(9):12000-16

PubMed: 23109896 ( click the link to review the publication )

Int J Oncol, 2012, 41(3):869-75

PubMed: 22752005 ( click the link to review the publication )

Cancer Res Treat, 2012, 44(3):202-9

PubMed: 23091447 ( click the link to review the publication )

PLoS One, 2012, 7(9):e42441

PubMed: 22957020 ( click the link to review the publication )

PLoS One, 2012, 7(12):e51549

PubMed: 23272116 ( click the link to review the publication )

Oncotarget, 2012, 2(12):1134-44

PubMed: 22193779 ( click the link to review the publication )

Mol Syst Biol, 2011, 7:486

PubMed: 21525872 ( click the link to review the publication )

Oncogene, 2011, 30(6):737-50

PubMed: 20890302 ( click the link to review the publication )

Antivir Res, 2011, 89(1):64-70

PubMed: 21094187 ( click the link to review the publication )

J Immunother, 2011, 34(4):372-81

PubMed: 21499124 ( click the link to review the publication )

Mol Biosyst, 2011, 7(12):3223-33

PubMed: 21956701 ( click the link to review the publication )

Exp Mol Pathol, 2011, 91(1):400-10

PubMed: 21565184 ( click the link to review the publication )

Vet Comp Oncol, 2011, 11(2):124-39

PubMed: 22235915 ( click the link to review the publication )

Int J Proteomics, 2011, 2011:215496

PubMed: 22091388 ( click the link to review the publication )

Carcinogenesis, 2010, 31(11):1948-55

PubMed: 20837598 ( click the link to review the publication )

产品安全说明书

EGFR抑制剂选择性比较

生物活性

产品描述

Gefitinib (ZD1839)是一种EGFR抑制剂，作用于NR6wtEGFR和NR6W细胞中的Tyr1173，Tyr992，Tyr1173和Tyr992，IC50 分别为37 nM，37nM，26 nM和57 nM。

特性

Gefitinib是有效的EGFR酪氨酸激酶抑制剂。

靶点

Tyr1173 (NR6W cells) ^[1]	Tyr1173 (NR6wtEGFR cells) ^[1]	Tyr992 (NR6wtEGFR cells) ^[1]	Tyr992 (NR6W cells) ^[1]
26 nM	37 nM	37 nM	57 nM

体外研究

Gefitinib 作用于高和低表达EGFR的细胞系，包括NR6, NR6M 和 NR6W 细胞系，有效抑制EGFR上全部酪氨酸磷酸化位点。磷酸化位点 Tyr1173和Tyr992敏感性较低，需要高浓度Gefitinib才能抑制。Gefitinib作用于NR6W细胞，高效阻断PLC-γ磷酸化, IC50为27nM。NR6wtEGFR 和NR6M细胞系具有低水平PLC-γ磷酸化， IC50 分别为 43 nM和 369 nM。Gefitinib抑制AKT磷酸化，作用于低EGFR和EGFRvIII表达的细胞系， IC50 分别为220 和263nM。Gefitinib按 0.1 到 0.5μM剂量处理，显著促进而不是废除 NR6M细胞形成集落。然而, 2μM Gefitinib 完全抑制 NR6M 集落形成。Gefitinib 作用于高和低EGFR表达的细胞系，EGF 刺激72小时后，快速抑制EGFR 和ERK 磷酸化，这种作用存在剂量依赖性。^[1]Gefitinib抑制 EGF驱动的未转化MCF10A 细胞生长，IC50为 20 nM。^[2] Gefitinib 作用于MDA-MB-231细胞，抑制EGF信号。Gefitinib严重抑制细胞数的增多，这种作用存在剂量依赖性。 ^[3]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
KB	NIPFNlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXXJR\|UxRTBwMEW0JO69VQ>?	MWexOlUyPjR5Mx?=
NIH3T3	NFKxOWlHfW6ldHnvckBCe3OjeR?=	NF\6U\|IxNjJizszN	M3vMTVIhcA>?	MofwSG1UVw>?	MmPTTY5pcWKrdHnvckBw\iCHR1[gd5RqdXWuYYTl[EBpfW2jbjDldoJDOSCjdYTvdIhwe3Cqb4L5cIF1cW:wIIfpeIghUUN3MDDv[kAxNjBzNESg{txO	M3rUd\|E3PDhyMki0
COS7	MnLBSpVv[3Srb36gRZN{[Xl?	NXXhR\|RHQTZizszN			NF;QcpZKdmirYnn0bY9vKG:oIHj1cYFvKEqDS{KgWlYyP0ZibYX0ZY51KGW6cILld5Nm\A>?	MlXFNVcyPzh5MkK=
A549	NFrrZnJEgXSxdH;4bYMhSXO\|YYm=		M4fHXFk3KGh?	M1\kOGROW09?	M37OW2lEPTB;MUOuOVkh\|ryP	MVOxPFMyOzhyNx?=
K562	M2XtemN6fG:2b4jpZ{BCe3OjeR?=		MWm5OkBp	NVLWcGd{TE2VTx?=	NUW4THpSUUN3ME25MlM3KM7:TR?=	MlfCNVg{OTN6MEe=
MDA-MB-231	MYrDfZRwfG:6aXOgRZN{[Xl?		M4KzWVk3KGh?	NYTJfWJ1TE2VTx?=	M{jTcWlEPTB;M{[uOlEh\|ryP	Mle2NVg{OTN6MEe=
MOLT4	M1jPU2N6fG:2b4jpZ{BCe3OjeR?=		NXT6[\|NHQTZiaB?=	M{jVd2ROW09?	Mk\ETWM2OD1zNT6wNkDPxE1?	NHrFbGoyQDNzM{iwOy=>
MCF7	NXrQPFJ{S3m2b4TvfIlkKEG\|c3H5	NGDvN2Q2OCEQvF2=	M2XZb\|czKGh?		NF6zW5dKSzVyPUGyMlA2KM7:TR?=	NEHZN5oyQDd5MUixPS=>
BT474	NYHWOW5TT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MlHIO\|IhcA>?		NX\EOY96SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDCWFQ4PCClZXzsd{BwfmW{ZYjwdoV{e2mwZzDFVmJjOiC5aYToJGVEPTBib3[gNE4{KM7:TR?=	NEjUNHMyQTB{OESyOC=>
HN5	NWT6eVVWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWDhPXBwPzJiaB?=		MnTMRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiCKTkWgZ4VtdHNib4\ldoV5eHKnc4PpcochTUeIUjD3bZRpKEWFNUCgc4YhOC5yMTFOwG0>	M3r2UVE6ODJ6NEK0
BA/F3	MlLqR5l1d3SxeHnjJGF{e2G7		M2L5S\|czKGh?		NHjlW\|lEgXSxdH;4bYNqfHliYXfhbY5{fCCvb4Xz[UBDSS:IMzDj[YxteyCneIDy[ZN{cW6pIFXHSnIhVDh3OGKgcZV1[W62IIfpeIghUUN3MDDv[kAxNjBzMEig{txO	NIm1eZUyQTJ\|OUKyPS=>
NIH3T3	M3zjXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MYS3NkBp		NWi5SZVOT3Kxd4ToJIlvcGmkaYTpc44hd2ZibX;1d4UhVkmKL{PUN{Bk\WyuczDlfJBz\XO\|aX7nJIVzSjJiZ3Xu[UB4cXSqIFnDOVAhd2ZiMD61OEDPxE1?	MYCxPVY3PTN5Nx?=
MCF7 MX	M3OzNWZ2dmO2aX;uJGF{e2G7		NXvl[XN2OzBibXnu		MYjJcohq[mm2aX;uJI9nKEKFUmCg[ZhxemW\|c3XkJJdqfGhiSVO1NEBw\iBzLkGg{txO	MmHlNVk6OzJ7NkC=
A431	NFv1VnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NWT5TZZuOTBizszN	NVrjb3U6PzJiaB?=		MnzNS2k2OD1yLkWxOEDPxE1?	MnPINVk6Pjl2NkW=
A431	M1LtdWtqdmG\|ZTDBd5NigQ>?	NXna[nE3OC5zIN88US=>	MVGxJIg>		M1nGVWlvcGmkaYTpc44hd2ZiRVfGMYlv\HWlZXSgSWdHWiCyaH;zdIhwenmuYYTpc44>	NX;6V\|dDOTl7Nkm0OlU>
A431	Mmf1T4lv[XOnIFHzd4F6	M3iwSlExOCEQvF2=	MmC0NVAhdWmw		MVnQdo9td26pZXSgbY5pcWKrdH;yfUBi[3Srdnn0fUBw\iCHR1[tbY5lfWOnZDDFS2ZTKHCqb4PwbI9zgWyjdHnvci=>	MVexPVk3QTR4NR?=
Sf9	M{j2[GtqdmG\|ZTDBd5NigQ>?		Mk\QNVAhdWmw	NFW1fJhFVVOR	MXjJcohq[mm2aX;uJI9nKEWJRmKg[ZhxemW\|c3XkJIF{e2W\|c3XkJIF{KGmwaHnibZRqd25ib3[gdoVk\XC2b4KgZZV1d3Cqb4PwbI9zgWyjdHnvckB4cXSqIFnDOVAhd2ZiMD6wN\|Mh\|ryP	M3\wOFIxODV4NEK1
NCI-H1975	NXm4[nZRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIrzWW02KM7:TR?=	MnnzO\|IhcA>?		MnnaTWM2OD16LkK2JO69VQ>?	NE\xXIozODF3MU[3NC=>
NCI-H1975	M4rjTmtqdmG\|ZTDBd5NigQ>?	NFuwVpgyOCEQvF2=			MoPsTY5pcWKrdHnvckBw\iCHR1\SJIF2fG:yaH;zdIhwenmuYYTpc44>	NUTNUIU2OjBzNUG2O\|A>
NCI-H1975	NWe3ZZJHTnWwY4Tpc44hSXO\|YYm=	M1HWXFExKM7:TR?=			NVHpUWQ{UW6qaXLpeIlwdiCxZjDFVmJDOiCjdYTvdIhwe3Cqb4L5cIF1cW:w	NGjFWmwzODF3MU[3NC=>
NCI-H1975	NFvpZVhHfW6ldHnvckBCe3OjeR?=	MUi1JO69VQ>?	NIrKcGQ1QCCq		MYPJcoR2[3Srb36gc4Yh[XCxcITvd4l{KGG\|c3Xzd4VlKGG\|IHHjeIl3[XSrb36gc4Yh[2G\|cHHz[U0{	NW\TU2FzOjBzNUG2O\|A>
A375	Mkj1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NUPGSlJQPDhiaB?=		NUC1fmR4UUN3ME2yNE42PSEQvF2=	Ml;3NlA{ODR3M{e=
SMMC7721	M{HudGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NV:4NllIPDhiaB?=		Mo\WTWM2OD1\|Mz6xNkDPxE1?	Ml25NlA{ODR3M{e=
DU145	NWPqNWY1S3m2b4TvfIlkKEG\|c3H5		NHvKRYY2KGR?	MlTYSG1UVw>?	NEPCZldKSzVyPUSyMlE4KM7:TR?=	MnPGNlA1PjZ3NUW=
MIAPaCa2	NVjXSIxmS3m2b4TvfIlkKEG\|c3H5		NIK5cWQ2KGR?	M1;0OWROW09?	M2T1N2lEPTB;NUCuOlIh\|ryP	NUHjOIVZOjB2Nk[1OVU>
PANC1	NGjOSm9EgXSxdH;4bYMhSXO\|YYm=		M2qyXFUh\A>?	MVrEUXNQ	MXjJR\|UxRTRyLkSyJO69VQ>?	M4nH[VIxPDZ4NUW1
PC9	NXPRNXZCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Moq4RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDFS2ZTNWSnZnnjbYVvfCCqdX3hckBRSzliY3XscJMhf2m2aDDFR\|UxKG:oIECuNFE4KM7:TR?=	MofXNlEzODh6MEK=
PC9	MmHPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGf2SmZCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIdzd3e2aD3y[ZNqe3SjboSgbJVu[W5iUFO5JINmdGy\|IHX4dJJme3OrbnegSWdHWiCHN{S2Y2E4PTBxVEe5NG0hdXW2YX70JJdqfGhiRVO1NEBw\iB5IN88US=>	M2rBR\|IyOjB6OECy
PC3	MkTxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYW3bHM4OTBizszN	MVe3NkBp	NFnkeFFFVVOR	MVPJR\|UxRTdwNDFOwG0>	MlmwNlE{PTN3NE[=
MDA-MB-468	NHXpS21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NYm0UFBqOTByIN88US=>	MV20PEBp	M{PCW2ROW09?	Mnu1RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdIm=	MmDXNlE1Ojl4M{K=
Plasmodium falciparum					NYLGd5RSeUiWUzDwdo9ncWyrbneg[o9zKGmwaHnibZRwenNib3[gVIxie22xZHn1cUBn[WylaYDhdpVuKHC{b3zp[oVz[XSrb36=	M{fiO\|IyQDF5MES1
NCI-H1993	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MUG3NkBp	MX;EUXNQ	NUfPc4UyUUN3ME2wMlEh\|ryP	MVyyNVkyPjR\|Mx?=
NCI-H292	NWHXdWxZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NHrKW244OiCq	NEGxbJFFVVOR	M{LCW2lEPTB;MD6wNkDPxE1?	NWm1W5U1OjF7MU[0N\|M>
A431	M3zYW2tqdmG\|ZTDBd5NigQ>?		M{\ifFIhcA>?	MYjEUXNQ	NHuyZXZKdmirYnn0bY9vKG:oIFXHSnIheGixc4Doc5J6dGG2aX;uJIlvKEWJRj3zeIlufWyjdHXkJIh2dWGwIFG0N\|Ehf2m2aDDJR\|UxKG:oIECuNFAyKM7:TR?=	M1nJOlIzOTBzMUOy
MCF7	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHjU[\|gyODEEoN88[{9uVA>?	NVzPNmNQPDhiaB?=	MXLEUXNQ	MUfBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IHj1cYFvKE2FRkegZ4VtdHNib4\ldoV5eHKnc4PpcochTUeIUjDn[Y5mKHerdHigTWM2OCCxZjCxNk4xPSEQvF2=	NFjKdWczOjFzOUGzNC=>
BT474	NYj2fnF{S3m2b4TvfIlkKEG\|c3H5	NHjxXm4yOCEQvF2=	NX\aRZcyPDhiaB?=		MUTDfZRwfG:6aXPpeJkh[WejaX7zeEB{\XK3bT3zeIFzfmWmIHj1cYFvKEKWNEe0JINmdGy\|	M{nyNlIzOTN6M{C4
MCF7	NV3qXlFyS3m2b4TvfIlkKEG\|c3H5	MXyxNEDPxE1?	M2jOU\|Q5KGh?		NHnFZWtEgXSxdH;4bYNqfHliYXfhbY5{fCC\|ZYL1cU1{fGG{dnXkJIh2dWGwIF3DSlch[2WubIOgc5Zmei2neIDy[ZN{cW6pIFXyZmIzKGOnbHzz	NFHSZoszOjF\|OEOwPC=>
HCC827	MojGT4lv[XOnIFHzd4F6	NUfFVYpHOC5zMkWg{txO	MlPsNlQhcA>?	MlviSG1UVw>?	M3jGTWlvcGmkaYTpc44hd2ZiRVfGVkBl\WxiRUe0Ok1CPzVyIH31eIFvfCC\MUC2PEBifXSxcHjvd5Bpd3K7bHH0bY9v	NFizVVczOjN\|OUO0Ni=>
HCC827	MmSzT4lv[XOnIFHzd4F6	Mnn4NE4yOjVizszN	M4TNSlI1KGh?	MoHOSG1UVw>?	NEfPRXNKdmirYnn0bY9vKG:oIFXHSnIh\GWuIFW3OFYuSTd3MDDteZRidnRvbXXkbYF1\WRiRYLrJJBpd3OyaH;yfYxifGmxbh?=	MkPxNlI{Ozl\|NEK=
HCC827	MoP1T4lv[XOnIFHzd4F6	NHu1bGoxNjF{NTFOwG0>	M2nzUlI1KGh?	M{DqOmROW09?	NUjibJN[UW6qaXLpeIlwdiCxZjDFS2ZTKGSnbDDFO\|Q3NUF5NUCgcZV1[W62LX3l[IlifGWmIFHreEBxcG:\|cHjvdplt[XSrb36=	NWrCNFFFOjJ\|M{mzOFI>
A431	MUDLbY5ie2ViQYPzZZk>	MWWxNFAh\|ryP	M13ERlMxKG2rbh?=		Ml7JTY5pcWKrdHnvckBw\iCHR1\SJIRmemm4ZXSg[pJwdSCqdX3hckBCPDNzIHPlcIwhdWWvYoLhcoUh[XO\|ZYPz[YQh[XNiaX7obYJqfGmxbjDv[kBxd2y7LVfseU1VgXJicHjvd5Bpd3K7bHH0bY9vKHerdHigTWM2OCCxZjCxMlA5KM7:TR?=	MVKyNlY6QDd6Mh?=
H460	MULDfZRwfG:6aXOgRZN{[Xl?		MUi3NkBp		NX\2UWtjUUN3ME21MlU6KM7:TR?=	M2\ob\|IzPzJ5NES5
HT-29	NEDJfohEgXSxdH;4bYMhSXO\|YYm=		MoiyO\|IhcA>?		MkDPTWM2OD1\|LkO2JO69VQ>?	MVmyNlczPzR2OR?=
SGC7901	NWrKbWpQS3m2b4TvfIlkKEG\|c3H5		NYfa[VRVPzJiaB?=		NHPpflVKSzVyPUGwMlI3KM7:TR?=	MUKyNlczPzR2OR?=
A498	NFrPWVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3XV[mFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUS5PEBk\WyuczDlfJBz\XO\|aX7nJGVITlJiYX7kJHNTSyC5aYToJGlEPTBib3[gPE43KM7:TR?=	NVrTWFV{OjJ6MUi4OFg>
Calu3	M2\XUmN6fG:2b4jpZ{BCe3OjeR?=	Mke0NVAh\|rypL33M	MoThO\|IhcA>?		MX3JR\|UxRTFwNjFOwG0>	NF\MN\|kzOzFzNkG2PC=>
FADU	M3S4WWN6fG:2b4jpZ{BCe3OjeR?=	MYKxNEDPxGdxbVy=	MUK3NkBp		MoDJTWM2OD1yLkC1JO69VQ>?	MUOyN\|EyPjF4OB?=
HCC827	NGS5flREgXSxdH;4bYMhSXO\|YYm=	M2nMNVExKM7:Zz;tUC=>	MlGzO\|IhcA>?		NEOzfopKSzVyPUCuNFAyPSEQvF2=	NWnoRYc5OjNzMU[xOlg>
PC9	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2PMN\|ExKM7:Zz;tUC=>	MlXhO\|IhcA>?		NHTFTFRKSzVyPUCuNFE1KM7:TR?=	MYiyN\|EyPjF4OB?=
Sf9	NFPyVVZMcW6jc3WgRZN{[Xl?		M4nSNFEhcA>?	NUTqXIV7TE2VTx?=	NI\yOnhKdmirYnn0bY9vKG:oIHj1cYFvKEeVVD30ZYdo\WRiRVfGVkBNQDN2UjDteZRidnRiZYjwdoV{e2WmIIfpeIghUUN3MDDv[kAxNjBzNTFOwG0>	MXKyN\|YyOTZ7MR?=
16HBE14o-	Mn;VR5l1d3SxeHnjJGF{e2G7	NFq3UXoyOCEQvF2=	MWi3NkBp	NV7TS4syTE2VTx?=	NYjV[nJTS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hOT[KQlWxOI8uKGOnbHzzJIhiemKxcnnu[{B4cWymIIT5dIUhTUeIUjDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckB4cXSqIFnDOVAhd2ZiMUKuO\|Eh\|ryP	M2fpV\|I{PjZ6NESx
NCI-H1975	NWjUWm1uS3m2b4TvfIlkKEG\|c3H5	NHnSPZAyOCEQvF2=	M4DjNFczKGh?	M2S2PWROW09?	M1Pzb2N6fG:2b4jpZ4l1gSCjZ3HpcpN1KGenZnn0bY5q[i2{ZYPpd5RidnRiaIXtZY4hVkOLLVixPVc2KGOnbHzzJIhiemKxcnnu[{BGT0[UIFy4OVhTN1R5OUDNJIRwfWKuZTDteZRidnRiYYPz[ZN{\WRiYYOg[5Jwf3SqIHnubIljcXSrb36ge4l1cCCLQ{WwJI9nKDZwOUG3JO69VQ>?	MUSyN\|Y3QDR2MR?=
16HBE	NXzKSXVjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVnSdVQ4PzJiaB?=	NGrUVpNFVVOR	MmnpRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDoeY1idiBzNljCSUBk\WyuczDlfJBz\XO\|aX7nJJdqdGRidInw[UBGT0[UIIfpeIghUUN3MDDv[kAyNjZyMTFOwG0>	NWHad5Z[OjN5OUKzNVg>
16HBE	Mk[zSpVv[3Srb36gRZN{[Xl?	MkP3NVAxKM7:TR?=	NWDVUINXOTVyIH3pci=>	M3G1bWROW09?	NUT1VnppUW6mdXP0bY9vKG:oIH7peJJq[yCxeHnk[UBxem:mdXP0bY9vKGmwIHj1cYFvKDF4SFLFJINmdGy\|IHX4dJJme3Orbnege4lt\CC2eYDlJGVITlJ?	MUeyN\|c6OjNzOB?=
A549	NYXYeIhoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MmLaO\|IhcA>?	M1j1bWROW09?	MoW0RY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDD3bYxlKHS7cHWgSWdHWi:tLWLhd{Bl\XCnbnTlcpQhcHWvYX6gRVU1QSClZXzsd{B4cXSqIFnDOVAhd2ZiND62NlYh\|ryP	MX[yN\|c6OjNzOB?=
SH-SY5Y	NUDoV4ZOS3m2b4TvfIlkKEG\|c3H5		MV[3NkBp		MkjnTWM2OD1zOD6yNUDPxE1?	NGr0OpQzOzh5MUmwPS=>
LoVo	MlW4T4lv[XOnIFHzd4F6		MVSyJEBp	M{[yWWROW09?	M17q[GlvcGmkaYTpc44hd2ZiRVfGVkBxcG:\|cHjvdplt[XSrb36ge4l1cCCLQ{WwJI9nKDBwME[yJO69VQ>?	Mmr6NlM6OzB7OUS=
PC9	NYPR[HpLU2mwYYPlJGF{e2G7		MkPwNkBp	M1;D[GROW09?	MWDJcohq[mm2aX;uJI9nKEWJRmKg[ZhwdiBzOTDk[YxmfGmxbjDhZ5RqfmG2aX7nJI12fGGwdDDwbI9{eGixconsZZRqd25iaX6gbJVu[W5iUFO5JINmdGy\|IIfpeIghUUN3MDDv[kAxNjByOEeg{txO	M3q2SlI{QTNyOUm0
HCC827	NU\uOXFLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MkTqO\|IhcA>?		M4q0bWlEPTB;MD6wNVIh\|ryP	MnH1NlM6PzNzNki=
A549	MkLlT4lv[XOnIFHzd4F6	NV7SR5E2OSEQvF2=	M2fRc\|EhcA>?	Mon5SG1UVw>?	NXLEc2FJUW6qaXLpeIlwdiCxZjDFS2ZTKGG3dH;wbI9{eGixconsZZRqd25id3n0bEBKSzVyIH;mJFAvODN7OTFOwG0>	NHHDS4IzOzl6OEO1OC=>
A549	NHe3[olHfW6ldHnvckBCe3OjeR?=	NHnheFgyKM7:TR?=	MV2xJIg>	MkLkSG1UVw>?	M1XufWNmdGy3bHHyJJVxfGGtZR?=	NFvJcnQzOzl6OEO1OC=>
HCC827	NYPSUIt{U2mwYYPlJGF{e2G7	NFnjbpgxNjVizszN	M2nYWFIhcA>?	Mmn3SG1UVw>?	M4LQVmlvcGmkaYTpc44hd2ZiRVfGVkBxcG:\|cHjvdplt[XSrb36gbY4h\2WoaYTpcoljNXKnc3nzeIFvfCCqdX3hckBJS0N6MkegZ4VtdHN?	M4K0dFI{QTl\|M{K4
HCC827	NV63bolqTnWwY4Tpc44hSXO\|YYm=	MlrRNE42KM7:TR?=	NX\QbHY5OiCq	NX7JWnBRTE2VTx?=	MWnJcohq[mm2aX;uJI9nKGNvTXX0JJBpd3OyaH;yfYxifGmxbjDpckBo\W[rdHnubYIuemW\|aYP0ZY51KGi3bXHuJGhESzh{NzDj[Yxtew>?	M1n4flI{QTl\|M{K4
HCC827	NVjIbVhDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	Mo\2NVAh\|ryP	MX[3NkBp	MmTZSG1UVw>?	MkHkRY51cXC{b3zp[oVz[XSrdnWgZYN1cX[rdImgZYdicW6\|dDDn[YZqfGmwaXKtd4Vve2m2aY\lJIh2dWGwIFjDR\|gzPyClZXzsd{Bp[XKkb4LpcochTUeIUjDFO\|Q3KHSxIFG3OVAh\GWuZYTpc44hf2m2aDDJR\|UxKG:oIECuNFA2QDFizszN	NWnZe3dEOjRyNUO2O\|Q>
A431	M4DM[mtqdmG\|ZTDBd5NigQ>?	MkfoNVAxKM7:TR?=	MWGzNEBucW5?		M130dWlvcGmkaYTpc44hd2ZiRVfGVkBqdiC\|aHXkJI1mdWK{YX7lJJZme2mlbHXzJJdqfGhiSVO1NEBw\iBzLkGg{txO	NXryfWl7OjRyOUS0N\|I>
BCRP-MDCK2	NG[1[I9HfW6ldHnvckBCe3OjeR?=	M2jRe\|EvQCEQvF2=	NWXJS5h[PzJiaB?=	MoWxSG1UVw>?	NYKwclZwUW6lcnXhd4Uhd2ZicHzhd41iKG2nbXLyZY5mKGW6cILld5Nqd25ib3[gRmNTWCCneIDy[ZN{cW6pIILldI9zfGW{IHflcoUhT0[S	MojiNlQyQDR{MUO=
BCRP-MDCK2	NXr0XpRNTnWwY4Tpc44hSXO\|YYm=	NHLFZ4YyNjhizszN	NHO1ZW84OiCq	MmnzSG1UVw>?	NXO5cnI4WmWmdXP0bY9vKG:oIIDsZZNu[SCvZX3idoFv\SCneIDy[ZN{cW:wIH;mJGJEWlBiZYjwdoV{e2mwZzDy[ZBwenSncjDn[Y5mKEeIUB?=	NUXQSppuOjRzOESyNVM>
MDCK	NWnOenBMS3m2b4TvfIlkKEG\|c3H5		NY\WU2M3PzJiaB?=	MVHEUXNQ	MUPHTVUxRTFwNEWg{txO	NIH5SoozPDF6NEKxNy=>
MDCK2	NHjFN29HfW6ldHnvckBCe3OjeR?=	M3\uVlEvQCEQvF2=	NGLkZVA4OiCq	MXjEUXNQ	Mlz4TY5pcWKrdHnvckBw\iCqdX3hckBDS1KSIHX4dJJme3OnZDDhd5Nme3OnZDDhd{BJd2WlaIP0JFM{OzR{IHHjZ5VufWyjdHnvckB4cXSqIFnDOVAhd2ZiMz6xPUDPxE1?	M3rCOlI1OTh2MkGz
A431	NVXTWJB5S3m2b4TvfIlkKEG\|c3H5		NVfBeWN{PzJiaB?=	M4fuTWROW09?	NI[2bopEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPDNzIHPlcIx{KGW6cILld5NqdmdiRVfGVkB4cXSqIFnDOVAhd2ZiMD61OUDPxE1?	MlS0NlQ1OTFzMkO=
Calu3	M4[5XWN6fG:2b4jpZ{BCe3OjeR?=		NIDlS244OiCq	MmjuSG1UVw>?	MY\DfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDDZYx2OyClZXzsd{BmgHC{ZYPzbY5oKEiHUkKge4l1cCCLQ{WwJI9nKDBwOUmg{txO	MoXMNlQ1OTFzMkO=
KB	M1ri[mtqdmG\|ZTDBd5NigQ>?	MVOxNEDPxE1?	M3H5UlEhcA>?	NV2zPXEzTE2VTx?=	M1PBemlvcGmkaYTpc44hd2ZiRVfGMZN1cW23bHH0[YQh[XW2b4Doc5NxcG:{eXzheIlwdiCxZjDFS2ZTKHerdHigTWM2OCCxZjCwMlAzPSEQvF2=	M3LFV\|I1PDFzMUKz
BEAS2B	NUnVZlJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYe1NEDPxE1?	NWDh[GtRPzJiaB?=	M{nXSmROW09?	NUTBPFBzUUN3ME2xN{46PCEQvF2=	M2\yVVI1PjB5NUmx
NCI-H1975	MUnGeY5kfGmxbjDBd5NigQ>?	MXOxNFAh\|ryP	M3jN[lE2OCCvaX6=	M2G5eGROW09?	M1XqTmlv\HWldHnvckBw\iCQTzDwdo9lfWO2aX;uJIlvKGi3bXHuJG5EUS2KMUm3OUBk\WyuczDoZZJjd3KrbnegSWdHWiCOOEW4Vk9VPzlyTTDteZRidnR?	M3HJ[FI1PjB5NUmx
Hela	NULPUGVPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWLmRodLOjRiaB?=	MknqSG1UVw>?	M2L0V2lEPTB;Mj62O{DPxE1?	NHXsWZAzPDd\|MUK4NS=>
HepG2	M1nEUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MkTHNlQhcA>?	M4K1ZWROW09?	M2nK[GlEPTB;Nj60NkDPxE1?	NIjzT2gzPDd\|MUK4NS=>
Sf9	NWXYVZJ1U2mwYYPlJGF{e2G7		NX;SfnduOTBibXnu	NU\LdYdUTE2VTx?=	MoTaTY5pcWKrdHnvckBw\iCjdYTvdIhwe3Cqb4L5cIF1cW:wIH;mJJJm[2:vYnnuZY51KGircz30ZYdo\WRiRVfGVkAp[W2rbn:gZYNq\CB4NEWtNVE5PiliZYjwdoV{e2WmIIfpeIghUUN3MDDv[kAxNjB{IN88US=>	MUGyOFc{OTJ6MR?=
SW620	NILLbGlEgXSxdH;4bYMhSXO\|YYm=		NHW3V5c1QCCq	NUX2fHlvTE2VTx?=	NXrmWJlPUUN3ME2yPE4zKM7:TR?=	MkjYNlQ6ODB3OUS=
HCC827	M2LIW2Z2dmO2aX;uJGF{e2G7	MXewMlUh\|ryP	MUKyJIg>	MYrEUXNQ	NV7zSWY6\G:nczDuc5QhcW6qaXLpeEBkNU2ndDDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIFHLWEBxcG:\|cHjvdplt[XSrb36=	NX3FPGlMOjN7OUOzNlg>
HCC827	NV;aSJZ{TnWwY4Tpc44hSXO\|YYm=	NXXJVpBsOC53IN88US=>	MVeyJIg>	NU\YbIZJTE2VTx?=	MkjT[I9meyCwb4SgbY5pcWKrdDDjMW1mfCCjc4Pld5Nm\CCjczDpcohq[mm2aX;uJI9nKHB2ND:0NkBxcG:\|cHjvdplt[XSrb36=	NXrDb3hDOjN7OUOzNlg>
HCC827	MmfpR5l1d3SxeHnjJGF{e2G7	MnHINE42KM7:TR?=	M2nvUVczKGh?	NUP5WJhyTE2VTx?=	NH\vbGtp[XNibn:gZ5l1d3SxeHnjbZR6	NIT4ZpEzOzl7M{OyPC=>
NCI-H1975	MontSpVv[3Srb36gRZN{[Xl?	M4LUTFExKM7:TR?=	NXfCUFhmQCCq	M{j0fWROW09?	NF65THhld2W\|IH7veEBqdmirYnn0bUBGT0[UIHHzd4V{e2WmIHHzJJJm\HWldHnvckBqdiCHUlugdIhwe3Cqb4L5cIF1cW:w	MX2yN\|EyPjF4OB?=
A431	NELVdJFMcW6jc3WgRZN{[Xl?	MVSxJO69VQ>?	MmHyNUBp	NGnHWGdFVVOR	MlLHbIF{KG6xIHnydoV3\XK\|aXLs[UBqdmirYnn0bY9vKG:oIFXHSnIh[XW2b4Doc5NxcG:{eXzheIlwdg>?	MV[yOFkxODV7NB?=
LNCaP	NHi5[pNHfW6ldHnvckBCe3OjeR?=	NF3VU5kyOCEQvF2=	MkDLNoghd3JiNDDo	Mof0SG1UVw>?	NHjCXGxld2W\|IH7veEBqdmirYnn0JIF2fG:yaH;zdIhwenmuYYTpc44hd2ZiaX3teY5weHW{aX\p[YQh\myjZz30ZYdo\WRiQn34JIF{e2W\|c3XkJIF{KGmwY3;ydI9z[XSrb36gc4YhYzN{UG3BWHA>	M3\XTFE5PjZ5M{Gy
H1975	MWTLbY5ie2ViQYPzZZk>	MWqxJO69VQ>?	M4nOeFI1KGh?	NWXRTFRKTE2VTx?=	Ml70[I9meyCwb4SgbY5pcWKrdDDFS2ZTKHCqb4PwbI9zgWyjdHnvckBqdiCqdX3hckBJOTl5NTDj[YxteyCqYYLic5JqdmdiRVfGVkBNQDV6Uj;UO\|kxVSCvdYThcpQ>	MViyOFYxPzV7MR?=
H1975	NFL3PYtHfW6ldHnvckBCe3OjeR?=	NGfSPIsyKM7:TR?=	NWPVVXhkOjRiaB?=	M1L1TWROW09?	NYTtfI0z\G:nczDuc5QhcW6qaXLpeEBGWkticHjvd5Bpd3K7bHH0bY9vKGmwIHj1cYFvKEhzOUe1JINmdGy\|IHjhdoJwemmwZzDFS2ZTKEx6NUjSM3Q4QTCP	NX3peXo6OjR4MEe1PVE>
HCC827	NHviWJRMcW6jc3WgRZN{[Xl?	Mn62NE4yOSEQvF2=	MXexJIg>	NVrmfYU2TE2VTx?=	MnzkbIF{KG6xIHnydoV3\XK\|aXLs[UBqdmirYnn0bY9vKG:oIFXHSnIh[XO\|ZYPz[YQh[XNicnXjc5Zmenlib3[gSWdHWiCjdYTvdIhwe3Cqb4L5cIF1cW:w	M{jHWVI1OTJ2OEm4
H1975	NVTwO49PU2mwYYPlJGF{e2G7	NH7RO3UxNjN\|IN88US=>	NI\KNm0zKGh?	NF:wcYpFVVOR	M4rH[IRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KGG\|c3Xzd4VlKGG\|IILl[JVkfGmxbjDpckBCU1RicHjvd5Bpd3K7bHH0bY9v	NHy4WGczPDF{NEi5PC=>
H1975	NUDIW4lzU2mwYYPlJGF{e2G7	NV3INIM6OC5\|MzFOwG0>	NV;xSIZEOiCq	M1XRXWROW09?	NYXpRnhZ\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJIRwfWKuZTDteZRidnRiYYPz[ZN{\WRiYYOgdoVlfWO2aX;uJIlvKEWUSzDwbI9{eGixconsZZRqd25?	M4qw[FI1OTJ2OEm4
H1975	M1\JWmtqdmG\|ZTDBd5NigQ>?	M2nhdVAvOzNizszN	MVOyJIg>	NEHSeGlFVVOR	M1;uUYRw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDkc5VjdGVibYX0ZY51KHCqb4PwbI9zgWyjdHnvci=>	M1;6XVI1OTJ2OEm4
H1975	NWD5UZdFU2mwYYPlJGF{e2G7	NYOyeJhMOC5zMkWg{txO	NXnNc5B5OjRiaB?=	MYrEUXNQ	NUPj[ZlX\G:nczDuc5QhcW6qaXLpeEBGT0[UIFy4OVhTN1R5OUDNJI12fGGwdDDZNVA3QCCjdYTvdIhwe3Cqb4L5cIF1cW:w	MkLRNlI{Ozl\|NEK=
H1975	MoSyT4lv[XOnIFHzd4F6	NYTwSZZvOC53IN88US=>	NGnHeG4zPCCq	MVXEUXNQ	Mn:4[I9meyCwb4SgbY5pcWKrdDDFS2ZTKEx6NUjSM3Q4QTCPIH31eIFvfC2vZXTpZZRm\CCHcnugdIhwe3Cqb4L5cIF1cW:w	NX\MRnFOOjJ\|M{mzOFI>
H1975	NI\lTGRMcW6jc3WgRZN{[Xl?	MnzWNE42KM7:TR?=	MlvKNlQhcA>?	NYPReFJiTE2VTx?=	M2PXN4Rw\XNibn;0JIlvcGmkaYSgSWdHWiCOOEW4Vk9VPzlyTTDteZRidnRvbXXkbYF1\WRiQXv0JJBpd3OyaH;yfYxifGmxbh?=	M4HSdlIzOzN7M{Sy
MIAPaCa2	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnLWNk42KM7:TR?=	M{n3d\|czKGh?	M4nUfGROW09?	NEDaZodp[XNibn:g[5Jwf3SqIHnubIljcXSrb36=	MWWyNFQ3PjV3NR?=
MIAPaCa2	NHLkO3ZEgXSxdH;4bYMhSXO\|YYm=	NFXoWooyKM7:TR?=	NUTNTWk3OTBiZB?=	NXHq[VRnTE2VTx?=	MYnoZZMhdm9iY4n0c5RwgGmlaYT5JIF{e2W\|c3XkJIF{KHO3cIDy[ZN{cW:wIH;mJINwdG:weTDmc5Ju[XSrb36=	MYGyNFQ3PjV3NR?=
MIAPaCa2	MW\BdI9xfG:\|aYOgRZN{[Xl?	MnPQNVAh\|ryP	Mm\zNlRpKG:{IES4JIg>	MWXEUXNQ	MnT1[I9meyCwb4SgbY5lfWOnIHHwc5B1d3Orcx?=	NWKxbpJpOjB2Nk[1OVU>
MIAPaCa2	NXjid29CSXCxcITvd4l{KEG\|c3H5	NVfscpFtOjBizszN	M2Hqc\|I1KGh?	NXjEelNmTE2VTx?=	MVrkc4V{KG6xdDDpcoR2[2ViYYDvdJRwe2m\|IHHzd4V{e2WmIHHzJINie3Cjc3WgN{Bi[3SrdnH0bY9v	MlfiNlA1PjZ3NUW=
EoL-1	M1nzfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFXMR29KSzVyPUWuNVchdk1?	M{HZUnNCVkeHUh?=
NCI-H720	NF\lVYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NY\nUHVtUUN3ME2yOk46OiCwTR?=	MlX3V2FPT0WU
NCI-SNU-5	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Ml3KTWM2OD1{OD6xPUBvVQ>?	MXnTRW5ITVJ?
EW-3	NIO3[I1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MojGTWM2OD12Nj6wOEBvVQ>?	NIHiVFdUSU6JRWK=
HCC2218	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3XIfWlEPTB;NUCuOVkhdk1?	MlnSV2FPT0WU
HuO-3N1	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVnOdHBCUUN3ME21Ok4xQSCwTR?=	M2f3cXNCVkeHUh?=
DB	MlfBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH3WbXRKSzVyPU[wMlk3KG6P	NFHI[XhUSU6JRWK=
HSC-4	M1\ScWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUnJR\|UxRTZzLkWzJI5O	NGDafVlUSU6JRWK=
DOK	NHrtb\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXHJR\|UxRTl\|Lk[yJI5O	NY\nfWlqW0GQR1XS
H9	NFnSTW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVrJR\|UxRTF\|Nz6yJI5O	MlHHV2FPT0WU
NCI-H292	M4rzXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXHJR\|UxRTF4Mj62OkBvVQ>?	MYPTRW5ITVJ?
HSC-2	NED2S2VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3u5WWlEPTB;MU[1MlU4KG6P	Ml3MV2FPT0WU
LU-65	NEO5eXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2\KcWlEPTB;MU[2MlYyKG6P	NF3RPZRUSU6JRWK=
BV-173	M1vz[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGraXYRKSzVyPUG4Ok42PSCwTR?=	NInkTZlUSU6JRWK=
LB2241-RCC	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkTSTWM2OD1zOUSuPVMhdk1?	MkPYV2FPT0WU
KG-1	NFXxUppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFPWN4hKSzVyPUKwOE4{PCCwTR?=	M2O2N3NCVkeHUh?=
CHL-1	Mk\3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYXJR\|UxRTJyOD61NUBvVQ>?	MVLTRW5ITVJ?
KYSE-140	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYDJR\|UxRTJyOT65OkBvVQ>?	NUHLNW85W0GQR1XS
DU-145	Mn7TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXjJR\|UxRTJzOT6wOEBvVQ>?	NH;qWlFUSU6JRWK=
EW-13	NIPaTnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVLDcVgyUUN3ME2yNlUvOSCwTR?=	MnL3V2FPT0WU
KYSE-450	NHfEZXdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoLiTWM2OD1{NEeuPVIhdk1?	NHXpT3VUSU6JRWK=
CAL-72	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYfqfpFCUUN3ME2yOlgvPzNibl2=	MWPTRW5ITVJ?
MEG-01	MoftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVXKfZZpUUN3ME2yO\|YvPzZibl2=	NGDjOnFUSU6JRWK=
HCE-T	MnTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmPVTWM2OD1{N{muO\|khdk1?	NHTNUY5USU6JRWK=
NCI-SNU-1	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYDJR\|UxRTJ6Mz6zNkBvVQ>?	M3HkUXNCVkeHUh?=
CAL-27	NH6xRoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3HmWmlEPTB;Mki5MlA5KG6P	Mmj4V2FPT0WU
BALL-1	M{Plcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVLsXHZsUUN3ME2yPVcvPDJibl2=	NF22UmxUSU6JRWK=
SBC-1	NHfsPIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmXZTWM2OD1\|MEeuO\|khdk1?	M1TwenNCVkeHUh?=
CAL-54	NHXt[HpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHG5SY1KSzVyPUOxNU4zOyCwTR?=	NXnQ[Fk1W0GQR1XS
TI-73	Mmf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2rGeWlEPTB;M{GyMlc2KG6P	MljZV2FPT0WU
P12-ICHIKAWA	NXG1PJB1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX3JR\|UxRTN{OD6wOkBvVQ>?	M{LxdXNCVkeHUh?=
ACHN	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVrJR\|UxRTN\|MT60JI5O	MVzTRW5ITVJ?
PC-14	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{XLeGlEPTB;M{OzMlQyKG6P	NHrhZ5BUSU6JRWK=
HCC1806	M{XtOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn7hTWM2OD1\|M{euOVEhdk1?	NX\GWVZmW0GQR1XS
SK-MEL-24	M4jy[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX;4bFZjUUN3ME2zN\|cvQDdibl2=	MXLTRW5ITVJ?
A4-Fuk	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2TZUWlEPTB;M{WwMlAzKG6P	Mk\wV2FPT0WU
ECC10	NGWzTIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYrJR\|UxRTN3Mj65OkBvVQ>?	NIThWY9USU6JRWK=
KASUMI-1	NUf5WpROT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmPMTWM2OD1\|Nk[uO\|Mhdk1?	MljlV2FPT0WU
CAL-33	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Moi3TWM2OD1\|N{CuPUBvVQ>?	M4PHZnNCVkeHUh?=
MDA-MB-175-VII	M1LqcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHnGXYdKSzVyPUO3PE45QCCwTR?=	NW\tUZV7W0GQR1XS
NUGC-3	NH24PJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX7JR\|UxRTRyMT64NUBvVQ>?	MV\TRW5ITVJ?
KY821	NFnKeFhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1Sx[GlEPTB;NEC4MlU4KG6P	NVy5N5NDW0GQR1XS
CTB-1	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoO5TWM2OD12MkSuOEBvVQ>?	NVLDR\|hbW0GQR1XS
DoTc2-4510	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF7zT5NKSzVyPUS0Nk4yOiCwTR?=	M3X5PHNCVkeHUh?=
EFO-27	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{n0U2lEPTB;NEW0Mlc1KG6P	MlTaV2FPT0WU
BPH-1	NUHzW41{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXnJR\|UxRTR7MT6xOkBvVQ>?	NX63TVE{W0GQR1XS
KYSE-270	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUnJR\|UxRTR7OD62OUBvVQ>?	NFjLT4JUSU6JRWK=
HO-1-N-1	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYG2UYJvUUN3ME21NFkvOjVibl2=	Mnr1V2FPT0WU
SK-MEL-1	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4TtTGlEPTB;NUGwMlk6KG6P	NUm4V4J1W0GQR1XS
MOLT-13	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoHNTWM2OD13MUSuPFIhdk1?	NFLsd2VUSU6JRWK=
TK10	NFjVR\|RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml[4TWM2OD13MUWuNVEhdk1?	M1P5fnNCVkeHUh?=
HN	NGntOWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoDkTWM2OD13MUeuN\|ghdk1?	MnLEV2FPT0WU
SCC-15	MlGyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUPVSndwUUN3ME21NlUvPjhibl2=	M3zHeHNCVkeHUh?=
NCI-H358	Ml2wS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NX\L[nQ2UUN3ME21NlcvPjZibl2=	MmXxV2FPT0WU
KYSE-180	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NITSSXpKSzVyPUWzNE43OiCwTR?=	MX7TRW5ITVJ?
NCI-H82	MnH4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoTtTWM2OD13NECuOUBvVQ>?	NFrWW5hUSU6JRWK=
NB7	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVjJR\|UxRTV2Nj6zNkBvVQ>?	M1\iPXNCVkeHUh?=
DSH1	NUixeWdZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2jMfWlEPTB;NU[2Mlg5KG6P	M{flZXNCVkeHUh?=
RS4-11	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlTJTWM2OD13NkiuOVkhdk1?	NFH2RXZUSU6JRWK=
CAN	M3Hk[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M37zUWlEPTB;NUiwMlc3KG6P	NFnCV\|NUSU6JRWK=
Ca9-22	MmfMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYTJR\|UxRTV6OD62OEBvVQ>?	MnnVV2FPT0WU
CAL-39	M2PsSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmXzTWM2OD13OU[uN{BvVQ>?	NInTT4hUSU6JRWK=
NCI-H1623	NUDWUYlGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1vEXGlEPTB;NUm5MlM3KG6P	NEPmcFNUSU6JRWK=
FADU	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGT3epdKSzVyPU[wOE43QSCwTR?=	M1HSVXNCVkeHUh?=
NB69	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3vjZ2lEPTB;NkG0MlM2KG6P	MVTTRW5ITVJ?
Ramos-2G6-4C10	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYnJR\|UxRTZ{MT60OkBvVQ>?	M3HsZXNCVkeHUh?=
LB1047-RCC	MlPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEfWTI1KSzVyPU[yOU4zQSCwTR?=	NIDjdXRUSU6JRWK=
MV-4-11	Mn:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUnJR\|UxRTZ{Nz63JI5O	M1K2cXNCVkeHUh?=
DBTRG-05MG	M32yb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4PWUGlEPTB;NkOyMlI5KG6P	MYHTRW5ITVJ?
ME-180	Mme4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{XpfGlEPTB;NkOyMlkhdk1?	NWDXZXBxW0GQR1XS
NBsusSR	NHPHXmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYn6[nFmUUN3ME22OFYvPTJibl2=	Mmm2V2FPT0WU
COR-L105	NWfTRXlkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYrJR\|UxRTZ4Mj61N{BvVQ>?	MmPtV2FPT0WU
ETK-1	MlTIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYTuW4RCUUN3ME22OlIvPTlibl2=	NHexZlBUSU6JRWK=
L-363	Mn7qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVzJR\|UxRTZ5MT65OEBvVQ>?	MWTTRW5ITVJ?
LU-134-A	Mmf2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEfFNnFKSzVyPUexPU4xQSCwTR?=	NITmXGpUSU6JRWK=
NCI-H1770	NU\ob29WT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVPJR\|UxRTd{Mj60JI5O	M{TOSXNCVkeHUh?=
HAL-01	NUPMcJZKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYXvRpBUUUN3ME23N\|QvPzFibl2=	NXf1[o84W0GQR1XS
COLO-684	M2[0RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2G0RmlEPTB;N{WzMlAyKG6P	M2DzcXNCVkeHUh?=
TE-6	Mn7tS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnTrTWM2OD15NkSuN\|Ehdk1?	NIjYS29USU6JRWK=
A431	M{S5[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NESxZmJKSzVyPUe4NE4xPCCwTR?=	M1TRfHNCVkeHUh?=
LU-135	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlqxTWM2OD15OEOuNFMhdk1?	M4LxbXNCVkeHUh?=
EC-GI-10	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXjJR\|UxRTd6OD61NkBvVQ>?	MlXmV2FPT0WU
TE-12	NGTBepBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXrROW1FUUN3ME24NlEvOTFibl2=	NWTDWnhJW0GQR1XS
LoVo	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4DybWlEPTB;OEW5MlA3KG6P	MmjRV2FPT0WU
23132-87	M{fITWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn7nTWM2OD16NkSuNlghdk1?	MXXTRW5ITVJ?
AU565	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mo\3TWM2OD16NkmuOkBvVQ>?	M1;yOnNCVkeHUh?=
DEL	NUDPOYZsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGO0NnJKSzVyPUi3O{43PSCwTR?=	M4LVWHNCVkeHUh?=
COR-L88	MmLnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFmzOpVKSzVyPUi4Nk4zPiCwTR?=	MWfTRW5ITVJ?
NCI-H2126	M{PsZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkfrTWM2OD16OEKuPFMhdk1?	M{\aTnNCVkeHUh?=
CAPAN-1	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M13xd2lEPTB;OEizMlI6KG6P	NV\qTIJHW0GQR1XS
BT-474	NGnGOIJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYfJR\|UxRTl\|OD6xOEBvVQ>?	NH3NNIxUSU6JRWK=
BHY	M{nXfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYTJR\|UxRTl5NT60PEBvVQ>?	NHjNZZdUSU6JRWK=
HT-3	NUHNNVhIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlO3TWM2OD17OEKuOFEhdk1?	M{XIV3NCVkeHUh?=
SK-NEP-1	NY\zWJh4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWXJR\|UxRTl6OT60OEBvVQ>?	NVmydmZDW0GQR1XS
MS-1	NFX5emxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHrXfWZKSzVyPUm5OE43QSCwTR?=	NWPNWYNnW0GQR1XS
DOHH-2	NGi0VmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4LRb2lEPTB;MT6wNFAzOSEQvF2=	MVTTRW5ITVJ?
NCI-H1304	Ml\GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIfIbVNKSzVyPUGuNFE3PDNizszN	MYHTRW5ITVJ?
EM-2	MkXkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmHaTWM2OD1zLkCzNFE3KM7:TR?=	NVS0VXZ5W0GQR1XS
MHH-PREB-1	MoXOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NY[0XmFuUUN3ME2xMlA5PDVzIN88US=>	NYDPPI1uW0GQR1XS
KU-19-19	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3X6[GlEPTB;MT6wPFU1OSEQvF2=	NFrQPVRUSU6JRWK=
NCI-H1648	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV7JR\|UxRTFwMUC2NVYh\|ryP	MVfTRW5ITVJ?
MKN1	MlXES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2Xic2lEPTB;MT6yNVk5PyEQvF2=	NX;Se5IyW0GQR1XS
SNU-449	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHL5Z4tKSzVyPUGuNlIzODhizszN	MUnTRW5ITVJ?
OAW-42	M3\3bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3XuNmlEPTB;MT6yO\|gzPSEQvF2=	M13UfXNCVkeHUh?=
769-P	M{fGOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHnOV\|lKSzVyPUGuNlc6OThizszN	MoHtV2FPT0WU
SW1088	NVL4WXJ2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYPmS24yUUN3ME2xMlI6PjB5IN88US=>	MXrTRW5ITVJ?
GCIY	NIjNcmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX;JR\|UxRTFwM{CxN\|Ih\|ryP	MlPXV2FPT0WU
CTV-1	M37wS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWTJR\|UxRTFwM{C4JO69VQ>?	M1PJb3NCVkeHUh?=
NCI-H1092	M33QN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NW\LXJNnUUN3ME2xMlMxQDVizszN	MXzTRW5ITVJ?
NKM-1	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYPJR\|UxRTFwM{K1PVch\|ryP	NVf2[3I6W0GQR1XS
NCI-H1650	M4TkcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFS2[mNKSzVyPUGuN\|M1QDJizszN	MmXGV2FPT0WU
SW954	NEjJd5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFuxPVRKSzVyPUGuN\|QxPDhizszN	M37KW3NCVkeHUh?=
SW48	NIPpPWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnTMTWM2OD1zLkO2OlE5KM7:TR?=	NWH1dFZiW0GQR1XS
SK-N-DZ	NHn6fppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHf3TYdKSzVyPUGuN\|Y6PDdizszN	NETKfpBUSU6JRWK=
KMOE-2	M2PFfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVLJR\|UxRTFwM{m4NVUh\|ryP	M3G4bnNCVkeHUh?=
NB5	M{XVWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIDNflNKSzVyPUGuOFA5QTRizszN	NVPYUZN5W0GQR1XS
CCRF-CEM	NEHle5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWPDZ4hDUUN3ME2xMlQyOTFizszN	M4fFW3NCVkeHUh?=
RH-1	MnjvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4XXb2lEPTB;MT60NVE{PiEQvF2=	MoPtV2FPT0WU
NCI-H526	M4e4bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmHYTWM2OD1zLkSzPFI3KM7:TR?=	NXjPdIk{W0GQR1XS
697	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3XtV2lEPTB;MT60OFExPCEQvF2=	MoS3V2FPT0WU
J82	M3vaemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYLpO5VyUUN3ME2xMlQ2PzZ4IN88US=>	NXnyV3A1W0GQR1XS
BE-13	M4K1VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3;vcGlEPTB;MT61NFY4OSEQvF2=	M3;RcXNCVkeHUh?=
SAS	Mk\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3W1dmlEPTB;MT61NVYzOiEQvF2=	NIfDNW5USU6JRWK=
SCC-25	M4X6ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn22TWM2OD1zLkWyN\|IzKM7:TR?=	MlHrV2FPT0WU
LAMA-84	MlrtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NU\VXXViUUN3ME2xMlU{QDF3IN88US=>	NVjhXVZsW0GQR1XS
HSC-3	M2Xlb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIfkeJlKSzVyPUGuOVQ{QCEQvF2=	MlixV2FPT0WU
BT-549	NHO5SpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUDlXZNjUUN3ME2xMlU5PzR5IN88US=>	NEn3WWJUSU6JRWK=
ML-2	Mom4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVj4dJdRUUN3ME2xMlY1ODJ7IN88US=>	NHnxWlhUSU6JRWK=
BB30-HNC	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXzJR\|UxRTFwNki5O\|Ih\|ryP	NYHRSnpIW0GQR1XS
PANC-03-27	M1\NOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M332OGlEPTB;MT63NFE{QSEQvF2=	MmO5V2FPT0WU
COLO-678	M3nzeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGTlOJlKSzVyPUGuO\|M1PDRizszN	MnToV2FPT0WU
NCI-H1666	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3r1e2lEPTB;MT63OFcxPCEQvF2=	NYTEeI5nW0GQR1XS
NCI-H209	NYSyR41GT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4jYZ2lEPTB;MT63O\|I3QSEQvF2=	MmX6V2FPT0WU
EPLC-272H	NW\2ZXJ4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M37pOGlEPTB;MT64OVU1QSEQvF2=	NXvxSXV4W0GQR1XS
OMC-1	Ml72S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX;JR\|UxRTFwOUm4PFgh\|ryP	NIrIbGRUSU6JRWK=
HCC70	M2\Qc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MV;JR\|UxRTJwMEC4NVUh\|ryP	M1\ue3NCVkeHUh?=
CAL-12T	NVHaOnl1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGHUfpNKSzVyPUKuNFE5PjFizszN	Mn;qV2FPT0WU
TGBC24TKB	NXTEUmxCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4jZTWlEPTB;Mj6wNlk3OSEQvF2=	NYC5bWU3W0GQR1XS
EKVX	Mk\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHS1dWZKSzVyPUKuNFQ6OzlizszN	NUi5O4RPW0GQR1XS
SW1116	NGTlSFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYrU[plHUUN3ME2yMlA3ODB7IN88US=>	NX\PToFtW0GQR1XS
NCI-H2009	M3nyd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVG0NWtzUUN3ME2yMlA3OjF2IN88US=>	M2Lac3NCVkeHUh?=
RPMI-8866	NVz4SopET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHrkW5BKSzVyPUKuNFg1QDFizszN	NUX6[nM4W0GQR1XS
KARPAS-45	NUjTXlZmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYXJR\|UxRTJwMUK0O\|kh\|ryP	MlXLV2FPT0WU
RXF393	NH\zcVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIr4NlNKSzVyPUKuNVMxOzZizszN	M4KyUHNCVkeHUh?=
786-0	NEP4VHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWDibpJEUUN3ME2yMlE5PDB4IN88US=>	NGnKTG5USU6JRWK=
SCC-4	Mke1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\TXmtKSzVyPUKuNlE4PzZizszN	NIjjVYtUSU6JRWK=
BT-20	NHzsVZFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVK0R3FsUUN3ME2yMlI3PzR2IN88US=>	NG\6WVlUSU6JRWK=
A498	NF[wU5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVizfIlUUUN3ME2yMlI6PDF3IN88US=>	MWjTRW5ITVJ?
IGROV-1	M1nGfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NI\zSXRKSzVyPUKuN\|EzOzdizszN	MWTTRW5ITVJ?
JVM-3	M{iwU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{fDdmlEPTB;Mj6zOFY1OyEQvF2=	MoLmV2FPT0WU
NCI-H2170	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoHwTWM2OD1{LkO0O\|g{KM7:TR?=	MlXrV2FPT0WU
EW-18	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGCxXlRKSzVyPUKuN\|U1PzFizszN	NIPHVHhUSU6JRWK=
KU812	NGLDOmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3z1Z2lEPTB;Mj6zOlc4QSEQvF2=	M1zMXnNCVkeHUh?=
NY	NFfoN21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEPkT2ZKSzVyPUKuN\|czPyEQvF2=	Mnj3V2FPT0WU
HTC-C3	NVHlb4tLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1ThU2lEPTB;Mj60NlI3PyEQvF2=	NVnQRZQ5W0GQR1XS
CFPAC-1	M2HOemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYDxeIt[UUN3ME2yMlQ{QDZ2IN88US=>	NUPaVIRqW0GQR1XS
HH	M2S3fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYPIdIhEUUN3ME2yMlQ6QDV2IN88US=>	MmLqV2FPT0WU
MKN7	M1u4Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXHJR\|UxRTJwNkK3OFgh\|ryP	MoTWV2FPT0WU
TE-8	M2PjTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFnhXZJKSzVyPUKuOlM3PTNizszN	NY\Cc\|F3W0GQR1XS
MC-IXC	MnfJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NILGUndKSzVyPUKuOlQ1PTNizszN	Mmq4V2FPT0WU
DMS-79	M{PwU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MonXTWM2OD1{Lk[5Nlg1KM7:TR?=	MX3TRW5ITVJ?
Detroit562	NXzIco5xT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3\ofGlEPTB;Mj62PVg1PSEQvF2=	MWrTRW5ITVJ?
HuP-T4	NWfRW\|M2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3;DTGlEPTB;Mj63NlgyQCEQvF2=	M2XyR3NCVkeHUh?=
QIMR-WIL	NX;qe\|BMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MU\JR\|UxRTJwN{W5OVIh\|ryP	NFHwUVNUSU6JRWK=
BB65-RCC	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVzJR\|UxRTJwOEC3NVMh\|ryP	M{XJeXNCVkeHUh?=
PC-3	Mk[0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV\JR\|UxRTJwOEOzNVch\|ryP	MlS3V2FPT0WU
OVCAR-3	NV21TFBbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWfJR\|UxRTJwOEW1PVQh\|ryP	MWjTRW5ITVJ?
KYSE-510	MkjUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXzJR\|UxRTJwOE[3PFYh\|ryP	MYnTRW5ITVJ?
HC-1	M2qwZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF\GUJZKSzVyPUKuPVQxOTJizszN	NVrhNJp1W0GQR1XS
NCI-H1693	MmW0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEDIT2VKSzVyPUKuPVU5QTdizszN	NITLRYNUSU6JRWK=
DU-4475	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2[4bmlEPTB;Mj65PVA2OiEQvF2=	M17Ue3NCVkeHUh?=
COLO-680N	Mnm3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXjJR\|UxRTNwMEC0PVUh\|ryP	M2L0S3NCVkeHUh?=
MN-60	MmnjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXTBT49OUUN3ME2zMlA1QTd2IN88US=>	NFzSelZUSU6JRWK=
BCPAP	NUnYUYpYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYW3R3FtUUN3ME2zMlA5Ojl3IN88US=>	MlzCV2FPT0WU
647-V	NUPNVVk5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mmj1TWM2OD1\|LkG2NlIh\|ryP	MkPyV2FPT0WU
HT-1376	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1LHVGlEPTB;Mz6yNFUxPiEQvF2=	MWDTRW5ITVJ?
NCI-H1793	MlXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYTJR\|UxRTNwMkGwPVgh\|ryP	MlvQV2FPT0WU
SW1463	NGrRdJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnT2TWM2OD1\|LkK2NVkzKM7:TR?=	MnvZV2FPT0WU
NCI-H727	Mn[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXrxUIZrUUN3ME2zMlM5PTh2IN88US=>	NIH6Xo1USU6JRWK=
LB771-HNC	NF\Zd\|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX7JR\|UxRTNwM{mxNlYh\|ryP	NWGxUIJxW0GQR1XS
D-542MG	NVHETpRnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV7hWpBuUUN3ME2zMlQ1OjJ{IN88US=>	NIHaTXhUSU6JRWK=
NTERA-S-cl-D1	NXPlemx3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYPJR\|UxRTNwNES5OVch\|ryP	NWrnbXZWW0GQR1XS
C8166	NV\MdVFMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mn\zTWM2OD1\|LkS2OVIyKM7:TR?=	NEDvO\|VUSU6JRWK=
639-V	MnP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkXGTWM2OD1\|LkW3O\|kzKM7:TR?=	MYHTRW5ITVJ?
TE-1	M131fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYThPHptUUN3ME2zMlU6OTZ7IN88US=>	NXPofWk{W0GQR1XS
OAW-28	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWrMVZJKUUN3ME2zMlU6PDJ4IN88US=>	NGjqN2FUSU6JRWK=
SK-LU-1	NXnnelZZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUjJR\|UxRTNwNkC2OFUh\|ryP	NIr1c\|NUSU6JRWK=
CaR-1	Mn72S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4j0eWlEPTB;Mz62NVA1QCEQvF2=	NFLaSGxUSU6JRWK=
A2780	M1PZeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4j0U2lEPTB;Mz62OFA5QSEQvF2=	MoXHV2FPT0WU
C2BBe1	M{TjXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX3QW\|NKUUN3ME2zMlY1PDB5IN88US=>	NIDTXXVUSU6JRWK=
SK-MES-1	NI\yW3BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHfCfXRKSzVyPUOuOlQ3OTRizszN	M1HLOXNCVkeHUh?=
PANC-10-05	Ml\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUDJR\|UxRTNwN{KwO\|Ih\|ryP	M{XqUHNCVkeHUh?=
J-RT3-T3-5	M{j6OWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV3GN2xnUUN3ME2zMlc2PDB4IN88US=>	NFfmV4JUSU6JRWK=
ES4	NXvtNGtUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{f5TGlEPTB;Mz64NlI5PiEQvF2=	NHT6PGFUSU6JRWK=
NCI-H28	MoryS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHL2eW1KSzVyPUOuPFI6PjFizszN	NHPkUW5USU6JRWK=
NCI-H1155	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUjJR\|UxRTNwOESxOVkh\|ryP	NEO2T4lUSU6JRWK=
KURAMOCHI	M2XTN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX;6T4txUUN3ME2zMlg3ODV4IN88US=>	M3XpfXNCVkeHUh?=
NCI-H69	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmCwTWM2OD1\|LkmwNVc5KM7:TR?=	MlnYV2FPT0WU
IST-MES1	NVXwb\|M3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVnJR\|UxRTNwOUSwNlkh\|ryP	M4K0enNCVkeHUh?=
NH-12	NUTTZXRsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MX7JR\|UxRTNwOUSxPFch\|ryP	MmX6V2FPT0WU
JVM-2	M1[2RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXnJR\|UxRTNwOUS3OVIh\|ryP	Mlq1V2FPT0WU
EW-16	NEX6b45Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1nCRmlEPTB;Mz65OVU4PyEQvF2=	MW\TRW5ITVJ?
NCI-H441	MnLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4PLS2lEPTB;Mz65O\|AyPCEQvF2=	NIPiW5ZUSU6JRWK=
RCC10RGB	NXva[nlkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4\MdWlEPTB;ND6wNVI1PiEQvF2=	NHX0XoxUSU6JRWK=
TCCSUP	M2flW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3f5OmlEPTB;ND6xNVA2KM7:TR?=	NHO4SXVUSU6JRWK=
HL-60	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4ftUGlEPTB;ND6xNlI1OSEQvF2=	M4rnbXNCVkeHUh?=
EW-11	NXnnOHNoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUG3Um9VUUN3ME20MlE{OjZzIN88US=>	MUTTRW5ITVJ?
KARPAS-299	Mn:2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4HQe2lEPTB;ND6zNVAyOyEQvF2=	MYjTRW5ITVJ?
SNU-C2B	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1XIfWlEPTB;ND6zOFY5PiEQvF2=	MnvlV2FPT0WU
LU-139	NXLvU4JXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGDL[2VKSzVyPUSuN\|czPDdizszN	NWfWNnNvW0GQR1XS
HCC1937	NYLtb2pZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEntcpBKSzVyPUSuN\|c6QTNizszN	M{HUV3NCVkeHUh?=
GR-ST	MmPVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVHJR\|UxRTRwNEOxPEDPxE1?	NVPUVpBXW0GQR1XS
SK-OV-3	M4r1ZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mmn0TWM2OD12LkS2NFQzKM7:TR?=	M4nVXHNCVkeHUh?=
A172	NIfY[4tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml;VTWM2OD12LkW1OVIyKM7:TR?=	M4PmXXNCVkeHUh?=
NB10	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHm3XphKSzVyPUSuOVk4QDFizszN	MXrTRW5ITVJ?
P30-OHK	M{TrdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGLwW4pKSzVyPUSuPFE6OjlizszN	MoC3V2FPT0WU
KYSE-520	NILL[JpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF7IdVFKSzVyPUSuPFgxOThizszN	NInDfFhUSU6JRWK=
KNS-62	Ml34S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1TuR2lEPTB;ND65NFgxPyEQvF2=	MXzTRW5ITVJ?
ES1	M2nPWGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3TLTmlEPTB;ND65OlA{PSEQvF2=	M1nueXNCVkeHUh?=
KOSC-2	Mor2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkDPTWM2OD12Lkm5PVU6KM7:TR?=	NFricGlUSU6JRWK=
TE-9	NWfGdJN6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWX0bIJMUUN3ME21MlAyPTJ3IN88US=>	NHPnd2lUSU6JRWK=
NCI-H1838	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEHPbJdKSzVyPUWuNFIxPzZizszN	MkLpV2FPT0WU
KP-N-YN	NYrZfWxFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUjJR\|UxRTVwMUK1PVEh\|ryP	M3jDVXNCVkeHUh?=
ALL-PO	Mor3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH:yUoJKSzVyPUWuNlI2QDdizszN	MVzTRW5ITVJ?
NOMO-1	Moj0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mnq0TWM2OD13LkKzNVc3KM7:TR?=	NGe4WWNUSU6JRWK=
CGTH-W-1	NYLPUFU4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXOwUWZwUUN3ME21MlM5PTh2IN88US=>	Ml:xV2FPT0WU
ATN-1	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlnyTWM2OD13LkSxNVg1KM7:TR?=	NFT4U2FUSU6JRWK=
AGS	MmD3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkjsTWM2OD13LkS5OlE5KM7:TR?=	MojDV2FPT0WU
SW13	M1K3O2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MV\JR\|UxRTVwNUOyOlUh\|ryP	NFz0doJUSU6JRWK=
SW1990	NH;FWFVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFy0OWpKSzVyPUWuOlIzQDVizszN	NETTSpFUSU6JRWK=
BFTC-905	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHO5bYlKSzVyPUWuOlU5PzhizszN	MoPQV2FPT0WU
RMG-I	NV3lfWZXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2e0RmlEPTB;NT62OVk1OiEQvF2=	MnftV2FPT0WU
HD-MY-Z	NIrRenRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEn2S2FKSzVyPUWuOlg2QDFizszN	M36weXNCVkeHUh?=
HCC1187	NEn5NWtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mnm2TWM2OD13LkexNFMzKM7:TR?=	MVrTRW5ITVJ?
HCC2998	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkPETWM2OD13LkexPFc4KM7:TR?=	M376RnNCVkeHUh?=
RT-112	NVPReIVxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWjJR\|UxRTVwOUCyOFUh\|ryP	NFLyemxUSU6JRWK=
CAKI-1	NXXPZWljT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXPJR\|UxRTZwMEC5PFUh\|ryP	NUXldFRxW0GQR1XS
HDLM-2	NEHWU\|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3jC[WlEPTB;Nj6wNVQ5QSEQvF2=	MWnTRW5ITVJ?
TE-10	NYDaTZpET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXLoNpVMUUN3ME22MlA1QDN\|IN88US=>	M{DMdnNCVkeHUh?=
KE-37	NGrVOmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MonxTWM2OD14LkC3NlU5KM7:TR?=	MmjzV2FPT0WU
RCM-1	Mlv6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUHJR\|UxRTZwMEe3NVkh\|ryP	MUHTRW5ITVJ?
Mewo	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MY\JR\|UxRTZwMUG0PFch\|ryP	NEe3PXlUSU6JRWK=
L-428	NHnm[41Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYHOOo1KUUN3ME22MlE5ODN5IN88US=>	NV\VS4o5W0GQR1XS
8-MG-BA	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3XhWWlEPTB;Nj6xPVM4QSEQvF2=	NGi1XplUSU6JRWK=
SK-MEL-28	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnX2TWM2OD14LkKwPVY4KM7:TR?=	Ml;0V2FPT0WU
VA-ES-BJ	NXfGV3NUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3G0emlEPTB;Nj6zNFQ3OiEQvF2=	NGLqc49USU6JRWK=
CAL-120	NImwOVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUHmcVh7UUN3ME22MlQ2OTZ{IN88US=>	MW\TRW5ITVJ?
GAMG	M2\2bGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{fOfGlEPTB;Nj61NFYzKM7:TR?=	NXS2Z\|hsW0GQR1XS
MSTO-221H	NHK4OY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFvxZVlKSzVyPU[uOVEyPyEQvF2=	NHrERoJUSU6JRWK=
GCT	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkO0TWM2OD14LkWzN\|g4KM7:TR?=	MYrTRW5ITVJ?
SH-4	MlfnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{nhdWlEPTB;Nj61PFg1PCEQvF2=	MWfTRW5ITVJ?
Calu-3	NEi2eHFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3HtZmlEPTB;Nj62OVU3QCEQvF2=	MWPTRW5ITVJ?
SK-HEP-1	Ml3lS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVLJR\|UxRTZwN{G3OVMh\|ryP	NYXZXJE2W0GQR1XS
PFSK-1	NVrCcY51T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoGyTWM2OD14LkezOFc5KM7:TR?=	MVTTRW5ITVJ?
NB12	NF7yT21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4n1emlEPTB;Nj63PFQxPCEQvF2=	NFP6[XFUSU6JRWK=
A388	NIPHZWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFzvWINKSzVyPU[uPFk2OiEQvF2=	NVuxc4Q5W0GQR1XS
KLE	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlPsTWM2OD14Lkm2OVE3KM7:TR?=	NYjPTpVQW0GQR1XS
TE-11	Mo\5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWrQOWJTUUN3ME23MlA1QTZ5IN88US=>	MVzTRW5ITVJ?
NCI-H2405	M13x[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1W0fWlEPTB;Nz6wPFM6OyEQvF2=	NF\OfGNUSU6JRWK=
OVCAR-4	NHrRcoNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4jOc2lEPTB;Nz6xOVM2KM7:TR?=	Ml;5V2FPT0WU
KP-N-YS	M1jjPGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlK5TWM2OD15LkG4NVQh\|ryP	MmrlV2FPT0WU
NOS-1	NUDMNWNZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoTzTWM2OD15LkK1PFI5KM7:TR?=	MVHTRW5ITVJ?
DMS-114	NUG4R2piT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXzJR\|UxRTdwMkm2N\|Eh\|ryP	MVLTRW5ITVJ?
NCI-H2030	NX31cY55T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlfUTWM2OD15LkOzOlk5KM7:TR?=	NYS3N5FjW0GQR1XS
HEL	NXeyUWtUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVnJR\|UxRTdwM{e1NlEh\|ryP	M36xOXNCVkeHUh?=
CAL-62	Mlm4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NELFPI5KSzVyPUeuN\|k5PjZizszN	NYHjdIJNW0GQR1XS
COLO-668	Mn\KS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnXTTWM2OD15LkSzPVY4KM7:TR?=	Ml:zV2FPT0WU
SKG-IIIa	MmLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXvJR\|UxRTdwNEWzPFEh\|ryP	NYXYZVZVW0GQR1XS
HCC1419	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mki1TWM2OD15LkS2PFM{KM7:TR?=	NF\IOohUSU6JRWK=
OS-RC-2	M{[3Wmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGLUSVVKSzVyPUeuOFk5QTRizszN	NUTidpVtW0GQR1XS
COLO-829	M1nMO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXPJR\|UxRTdwNk[0OlMh\|ryP	MWrTRW5ITVJ?
NB13	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmG2TWM2OD15LkiyOlY4KM7:TR?=	MoLsV2FPT0WU
DK-MG	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYe2UZoxUUN3ME23Mlg{OjBzIN88US=>	NUDTUXdoW0GQR1XS
SHP-77	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3HVdGlEPTB;Nz64OlY2OyEQvF2=	MX\TRW5ITVJ?
NCI-H661	MlvVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnH6TWM2OD16LkC1PFY4KM7:TR?=	MnP1V2FPT0WU
AM-38	NIG4ZpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHPHOXZKSzVyPUiuNVYzQCEQvF2=	MlTJV2FPT0WU
VM-CUB-1	NHnPVnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4PEW2lEPTB;OD6xO\|AzQSEQvF2=	M2O2WnNCVkeHUh?=
KYSE-70	M4fvRWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFHpSJlKSzVyPUiuNVk4PjFizszN	M13O[XNCVkeHUh?=
5637	NUX4RYNyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1\lSWlEPTB;OD6zNVA2PSEQvF2=	NVPRUXNqW0GQR1XS
TGBC11TKB	NHjjUIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4TxTGlEPTB;OD60OlE3PCEQvF2=	MYjTRW5ITVJ?
EGI-1	Mmn2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYXlSFBNUUN3ME24MlYxODh6IN88US=>	Ml\MV2FPT0WU
D-392MG	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWPYS4RUUUN3ME24MlY3OjF2IN88US=>	NFrJcW1USU6JRWK=
A673	M1nUSWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4nXfmlEPTB;OD62O\|YyOSEQvF2=	M2PwZnNCVkeHUh?=
COLO-792	Mm[yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWTXVZZYUUN3ME24Mlc1QTR4IN88US=>	MX7TRW5ITVJ?
NCI-H1792	NI\ETVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEjFeY5KSzVyPUiuPFg6ODNizszN	NX7rOod[W0GQR1XS
LS-1034	NY[wd2l7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWfaZYZOUUN3ME24Mlk1PjV{IN88US=>	MkXWV2FPT0WU
D-566MG	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4W3b2lEPTB;OT6wNVgyKM7:TR?=	NI\mWW9USU6JRWK=
NCI-H226	NGW0dIFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M36wXmlEPTB;OT6wPUDPxE1?	MofOV2FPT0WU
ChaGo-K-1	M{fuO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWLJR\|UxRTlwMUC1O\|kh\|ryP	NVrs[GlvW0GQR1XS
NCI-H2228	NEPkN4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mo\XTWM2OD17LkGxNFgyKM7:TR?=	M4XkO3NCVkeHUh?=
RPMI-8226	M3H1Vmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2jUU2lEPTB;OT6xNVMxPCEQvF2=	NWjsTJM5W0GQR1XS
BFTC-909	M2nU[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MULJR\|UxRTlwMUiyPVch\|ryP	NGrFcJNUSU6JRWK=
HPAF-II	NWTyRYlwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEjOT5lKSzVyPUmuNlI2OThizszN	NUXETIZ7W0GQR1XS
Capan-2	MkXKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHq4cpJKSzVyPUmuOFAyODlizszN	M{TJS3NCVkeHUh?=
IA-LM	M3;uXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWrFR3FXUUN3ME25MlQyQTZ4IN88US=>	NXywPI5qW0GQR1XS
KP-4	NEGyXFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkSxTWM2OD17LkS4PFM5KM7:TR?=	Ml:wV2FPT0WU
A101D	NY\U[W1qT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MojQTWM2OD17LkWxO\|E6KM7:TR?=	MlezV2FPT0WU
EFO-21	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWTJR\|UxRTlwNUi3N\|Uh\|ryP	MX\TRW5ITVJ?
C32	M{PjXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUTBRW1kUUN3ME25MlY{OzRizszN	NEXLWIlUSU6JRWK=
SW837	NXHDNZRWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3vnbWlEPTB;OT64OFgzKM7:TR?=	Mm\DV2FPT0WU
OCI-AML2	M3j4VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXzUOIlwUUN3ME25Mlg3QTZizszN	MlnBV2FPT0WU
NCI-H1355	NEnJcWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXPiUXFkUUN3ME25Mlk1ODh6IN88US=>	NVfOSGVEW0GQR1XS
NCI-H2342	M3LGb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NG[1dHlKSzVyPUGwMlAyPTVizszN	NUnOV4N5W0GQR1XS
A204	NV7lcXhsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mmf6TWM2OD1zMD6wOFY3KM7:TR?=	M1X6enNCVkeHUh?=
CAL-51	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mlz5TWM2OD1zMD6wPFc4KM7:TR?=	MXLTRW5ITVJ?
HCE-4	NHzjcnJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVPJR\|UxRTFyLkGxNlIh\|ryP	NWHwV5JMW0GQR1XS
NCI-H810	NXjxOI57T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTFyLkG1PVch\|ryP	NUjYc2F{W0GQR1XS
DJM-1	NVXleXlPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVnJR\|UxRTFyLkG3N\|Ih\|ryP	MmO5V2FPT0WU
SK-UT-1	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn\GTWM2OD1zMD6yOVc1KM7:TR?=	MkWxV2FPT0WU
U031	NG\PWlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWPNeHRMUUN3ME2xNE4zPjh4IN88US=>	M3q0[3NCVkeHUh?=
YH-13	M4C1e2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MV3JR\|UxRTFyLkOwOVch\|ryP	NYDCcooxW0GQR1XS
K5	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFmyfpBKSzVyPUGwMlM{QTVizszN	Ml\EV2FPT0WU
HEC-1	M2PLfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIfxdGFKSzVyPUGwMlQxQDFizszN	NWPOdFZ2W0GQR1XS
A2058	M4[xc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1f0c2lEPTB;MUCuOVQ6OSEQvF2=	NULyVotuW0GQR1XS
SW962	NEToT4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{PKUGlEPTB;MUCuOlIxPCEQvF2=	NIXyOZZUSU6JRWK=
VMRC-RCZ	Mn7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGPFXnBKSzVyPUGwMlY4PDlizszN	M4TBcHNCVkeHUh?=
D-336MG	MlLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkTETWM2OD1zMD63NFA2KM7:TR?=	NXnsTVJUW0GQR1XS
LXF-289	NIXpUpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2PqVmlEPTB;MUCuO\|k3PyEQvF2=	Mn;2V2FPT0WU
SW900	NEL3TW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHnYVJpKSzVyPUGwMlgzOjhizszN	NXToWmJkW0GQR1XS
K-562	MlTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2O1SmlEPTB;MUCuPFM6PSEQvF2=	MlXIV2FPT0WU
HCC38	M4\XR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{fWOWlEPTB;MUCuPVcyPiEQvF2=	M1LwUXNCVkeHUh?=
SF-295	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{C3SmlEPTB;MUCuPVkxOiEQvF2=	NUDkTZZQW0GQR1XS
LB831-BLC	M3TrbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NG\J[VVKSzVyPUGxMlI2PTZizszN	M4rWfXNCVkeHUh?=
FTC-133	M363fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NITFV49KSzVyPUGxMlMxQDFizszN	MoWzV2FPT0WU
HCC1954	M1iz[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoTaTWM2OD1zMT60N\|Yh\|ryP	NHq3NJRUSU6JRWK=
GOTO	NWP1Rpl4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFfPXGtKSzVyPUGxMlUzODZizszN	NYPQZ5Q6W0GQR1XS
LS-411N	M1;XdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXPPZ\|hLUUN3ME2xNU43OTBzIN88US=>	NV\RepBtW0GQR1XS
RPMI-7951	NEPVcppIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4W5fWlEPTB;MUGuOlM1QCEQvF2=	MUXTRW5ITVJ?
NCI-H1299	MnrmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1Tl[mlEPTB;MUGuOlY1PyEQvF2=	MmPwV2FPT0WU
MLMA	M3vuOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIHl[2tKSzVyPUGxMlY6QTdizszN	MoPzV2FPT0WU
MMAC-SF	NELYTYZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYLJR\|UxRTFzLkeyOVIh\|ryP	NGKxOodUSU6JRWK=
UM-UC-3	MoPmS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVXJR\|UxRTFzLke0NlEh\|ryP	MmfIV2FPT0WU
SCC-9	NYf1NW52T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Moi0TWM2OD1zMT64NVUyKM7:TR?=	NXG5[XkzW0GQR1XS
HOS	MkTjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml3JTWM2OD1zMT64Olg{KM7:TR?=	NIf6UnZUSU6JRWK=
OE19	MofzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWLJR\|UxRTFzLkmzOlch\|ryP	MYLTRW5ITVJ?
Mo-T	Mn;6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MY\JR\|UxRTFzLkm1OFEh\|ryP	M2e0SHNCVkeHUh?=
CAMA-1	Mn\NS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYjJR\|UxRTF{LkG2N\|Mh\|ryP	MmfUV2FPT0WU
U-118-MG	M3vNbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGjCO4pKSzVyPUGyMlI1PDFizszN	MUHTRW5ITVJ?
KS-1	NELWNHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlOzTWM2OD1zMj6yPFMzKM7:TR?=	M3HEWXNCVkeHUh?=
JAR	NYXCdWp{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NW[zZZlJUUN3ME2xNk4{OzZ7IN88US=>	M4\YUHNCVkeHUh?=
ABC-1	MmDaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NE[zUZZKSzVyPUGyMlM1OSEQvF2=	MYjTRW5ITVJ?
Daoy	NUjQemZ1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUnscIlvUUN3ME2xNk41PTR{IN88US=>	MY\TRW5ITVJ?
C3A	NF;oXHRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mk\RTWM2OD1zMj61O\|g2KM7:TR?=	MXzTRW5ITVJ?
GT3TKB	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHz5ToFKSzVyPUGyMlY{OjdizszN	MlzpV2FPT0WU
DMS-273	MkPWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWrKS4Z5UUN3ME2xNk45PjN\|IN88US=>	MnTPV2FPT0WU
G-361	NFLIUZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXexUJBVUUN3ME2xNk46OTJ7IN88US=>	NYrWXFZDW0GQR1XS
RH-18	NHTtTVFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUnJR\|UxRTF\|LkK5OlIh\|ryP	M17LbHNCVkeHUh?=
SN12C	NVrSWZpCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWK1eYltUUN3ME2xN{4{QDB6IN88US=>	MX7TRW5ITVJ?
NCI-H1993	M1HHXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUHlbplJUUN3ME2xN{41Ojh3IN88US=>	NWTiNG5zW0GQR1XS
LOXIMVI	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M33Yc2lEPTB;MUOuOlE2OSEQvF2=	M1zzdXNCVkeHUh?=
SK-PN-DW	M1jpO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXnTVnEyUUN3ME2xN{45PDJ5IN88US=>	MVLTRW5ITVJ?
KALS-1	MorjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2DMW2lEPTB;MUOuPFUzPSEQvF2=	NGXCVINUSU6JRWK=
LAN-6	Mn25S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\iXoZKSzVyPUG0MlI2OyEQvF2=	MWTTRW5ITVJ?
A549	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX;JR\|UxRTF2LkS3NVIh\|ryP	M2\keXNCVkeHUh?=
RD	M2nsS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGXOZ5lKSzVyPUG0MlQ5OTNizszN	Mn[yV2FPT0WU
TGBC1TKB	M{ftbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGPhPWxKSzVyPUG0MlY3OTVizszN	NHfDXotUSU6JRWK=
NCI-H630	MknQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoXDTWM2OD1zND65OFY4KM7:TR?=	M1\DZnNCVkeHUh?=
MIA-PaCa-2	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWfJR\|UxRTF2Lkm2PUDPxE1?	NFfVfHZUSU6JRWK=
NCI-H1755	NHvEdpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIfQNYtKSzVyPUG0Mlk6PTNizszN	M3LIUHNCVkeHUh?=
MOLT-4	MlqwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mnu1TWM2OD1zNT6wOFk4KM7:TR?=	MlPrV2FPT0WU
CW-2	MkSwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUPEPXZDUUN3ME2xOU4yPDJzIN88US=>	NF3VRXFUSU6JRWK=
COLO-320-HSR	M{i5NGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVPJR\|UxRTF3LkWzNFch\|ryP	NF3iNXdUSU6JRWK=
UMC-11	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnjjTWM2OD1zNT63OVI{KM7:TR?=	MnzWV2FPT0WU
MCF7	Mln0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mo\YTWM2OD1zNT64NVQ2KM7:TR?=	MX\TRW5ITVJ?
NCI-H23	NFzQWWhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHfad5pKSzVyPUG1Mlg1OzhizszN	Ml2zV2FPT0WU
HuCCT1	NIX0eWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFnIWY5KSzVyPUG1Mlg4PCEQvF2=	NVz5WIw3W0GQR1XS
MPP-89	MonRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{nRT2lEPTB;MUWuPVQyPyEQvF2=	MnnrV2FPT0WU
HT55	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUnBOGFSUUN3ME2xOU46PDd6IN88US=>	Mon0V2FPT0WU
no-11	M4K5dWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3KzOmlEPTB;MUWuPVY3OyEQvF2=	NXPoSplCW0GQR1XS
GP5d	MlPUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{WwN2lEPTB;MU[uNlE5PyEQvF2=	NGfJTmNUSU6JRWK=
BHT-101	NHnLW\|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVvJR\|UxRTF4LkK0N\|kh\|ryP	M1TwTXNCVkeHUh?=
M059J	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MY\JR\|UxRTF4LkK4OEDPxE1?	MlPtV2FPT0WU
D-283MED	MkDqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH3jfmxKSzVyPUG2MlQzODlizszN	NH;FNIZUSU6JRWK=
BEN	MmrBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NULONZcyUUN3ME2xOk42OTV3IN88US=>	MojHV2FPT0WU
LB373-MEL-D	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVLJR\|UxRTF4LkeyN\|Ih\|ryP	M3riT3NCVkeHUh?=
MEL-HO	NXraW\|RPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmD4TWM2OD1zNj64PFU1KM7:TR?=	NVzLOHFYW0GQR1XS
GI-ME-N	MmXFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmfjTWM2OD1zNj65NFMzKM7:TR?=	MnnlV2FPT0WU
RKO	NFiyOpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4\CXGlEPTB;MUeuNFc1QCEQvF2=	M2m1dnNCVkeHUh?=
MZ2-MEL	NEXobllIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnnuTWM2OD1zNz6xN\|Mh\|ryP	M1L5VXNCVkeHUh?=
NCI-H1573	M1PrRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn3YTWM2OD1zNz6yPFI3KM7:TR?=	Mmf6V2FPT0WU
NCI-H1581	MlW1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVPJR\|UxRTF5LkS0NVEh\|ryP	NITkSZpUSU6JRWK=
NCI-H747	NWDNUVJST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVTJR\|UxRTF5LkWyPVch\|ryP	MXfTRW5ITVJ?
SW1783	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXHyUnZZUUN3ME2xO{43PDF3IN88US=>	NHfURmJUSU6JRWK=
Calu-6	M2K3UGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlznTWM2OD1zNz62O\|gzKM7:TR?=	M3XoT3NCVkeHUh?=
SF268	M1r4eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MorMTWM2OD1zNz62PVY6KM7:TR?=	M1rQW3NCVkeHUh?=
ES8	NYDkNJZbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4TlN2lEPTB;MUeuPFU6OyEQvF2=	MULTRW5ITVJ?
KM-H2	MlrPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MorHTWM2OD1zNz65OFEyKM7:TR?=	MVfTRW5ITVJ?
D-502MG	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2\3cGlEPTB;MUeuPVgxQCEQvF2=	Mmi3V2FPT0WU
HLE	NV;odpVpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIm4S5FKSzVyPUG4MlMyPDhizszN	NE\CPWNUSU6JRWK=
SW982	M{[zWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnnRTWM2OD1zOD60NFc2KM7:TR?=	NI[2[ZlUSU6JRWK=
MDA-MB-361	MmHoS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NULMcZRKUUN3ME2xPE42PTh6IN88US=>	MV\TRW5ITVJ?
NCI-H1563	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGHQbVNKSzVyPUG4MlcyOjRizszN	NVq1UotXW0GQR1XS
MFE-280	NEfJTm5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUTqTJBLUUN3ME2xPE44Ojl\|IN88US=>	NXqxcFJZW0GQR1XS
U251	NIjFTlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2OybGlEPTB;MUiuO\|M1PyEQvF2=	MYrTRW5ITVJ?
KNS-42	NWnCVWRET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Ml2wTWM2OD1zOD64NFE2KM7:TR?=	MkDZV2FPT0WU
U-266	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUfwPXJ{UUN3ME2xPE45PjR7IN88US=>	NVjRZo9xW0GQR1XS
OVCAR-8	NGPkbnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWjJR\|UxRTF6LkmyO\|Yh\|ryP	MmrmV2FPT0WU
MFH-ino	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MW\JR\|UxRTF6Lkm2Olkh\|ryP	Ml\DV2FPT0WU
D-263MG	M{HafWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXfJR\|UxRTF7LkCxO\|Ih\|ryP	NIKxdmlUSU6JRWK=
NCI-H1437	M1K4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MU\JR\|UxRTF7LkC0Olch\|ryP	M1\pSnNCVkeHUh?=
NCI-H1048	M2rwTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV3nbnZQUUN3ME2xPU4zOzJ4IN88US=>	MW\TRW5ITVJ?
NCI-H446	NXzMeWk3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWDJR\|UxRTF7LkO1PFkh\|ryP	NEDsOFhUSU6JRWK=
NCI-N87	MmHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYDJR\|UxRTF7LkW5PVIh\|ryP	Mn\vV2FPT0WU
WM-115	NVTiSVkzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MULJR\|UxRTF7Lk[3O\|Qh\|ryP	NXLuXI9IW0GQR1XS
HuH-7	Mn\rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXnJR\|UxRTF7Lke0NlEh\|ryP	M{mxR3NCVkeHUh?=
NCI-H650	NVPUUZB6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXLJR\|UxRTF7Lke1NFgh\|ryP	MVTTRW5ITVJ?
TYK-nu	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnW0TWM2OD1zOT64N\|c5KM7:TR?=	MX;TRW5ITVJ?
Becker	M3ThSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4nBUGlEPTB;MUmuPFU1PyEQvF2=	MVfTRW5ITVJ?
BB49-HNC	NUHDT\|dIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGPDZlFKSzVyPUG5MlkzKM7:TR?=	MoTVV2FPT0WU
HGC-27	M1\DZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MW\JR\|UxRTJyLkGzPVQh\|ryP	NG\wVGNUSU6JRWK=
SiHa	M{DwRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml;JTWM2OD1{MD6zO\|EzKM7:TR?=	M{G4XHNCVkeHUh?=
LB2518-MEL	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmfkTWM2OD1{MD6zO\|M6KM7:TR?=	NF;xO49USU6JRWK=
TE-5	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoXvTWM2OD1{MD63OFgzKM7:TR?=	MXnTRW5ITVJ?
IST-SL1	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MY\JR\|UxRTJyLke4O\|kh\|ryP	M1v4b3NCVkeHUh?=
A375	NFfnVZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHPJPJhKSzVyPUKxMlA2PjdizszN	MV\TRW5ITVJ?
MC116	NXjQcFRsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUPJR\|UxRTJzLkC3NlMh\|ryP	NHTZVGxUSU6JRWK=
GI-1	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M17ZN2lEPTB;MkGuNVch\|ryP	M4riW3NCVkeHUh?=
HOP-62	M3XMcGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXPuUFhrUUN3ME2yNU4zPzh2IN88US=>	MWHTRW5ITVJ?
PA-1	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoXDTWM2OD1{MT6yO\|g4KM7:TR?=	MlvLV2FPT0WU
HT	Mk\mS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3rIOmlEPTB;MkGuOFM{OSEQvF2=	MorWV2FPT0WU
HUTU-80	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlK5TWM2OD1{MT60N\|M3KM7:TR?=	NVPrSJRqW0GQR1XS
NCI-H1975	NGLzT21Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYDJR\|UxRTJzLkS2NUDPxE1?	MXnTRW5ITVJ?
GAK	NEnwdWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoXuTWM2OD1{MT60PVkh\|ryP	M1vhS3NCVkeHUh?=
SK-N-AS	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUDJR\|UxRTJzLkW2NVkh\|ryP	NFe0ZplUSU6JRWK=
OE33	M1fpV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWLJR\|UxRTJzLk[wOFYh\|ryP	NFnmcW9USU6JRWK=
YKG-1	M4jNdGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml\GTWM2OD1{MT62OVQ2KM7:TR?=	MkfqV2FPT0WU
CAL-85	NHO2T\|hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnjHTWM2OD1{MT65N\|A2KM7:TR?=	MVzTRW5ITVJ?
NCI-H2347	Mk\FS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX\JR\|UxRTJzLkm0Nlgh\|ryP	MlXjV2FPT0WU
PANC-08-13	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2T5[2lEPTB;MkKuNFEyQSEQvF2=	Mn3IV2FPT0WU
SK-N-FI	M4joe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{XKd2lEPTB;MkKuN\|A4PCEQvF2=	M3PmeXNCVkeHUh?=
NEC8	M1TKT2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3;acWlEPTB;MkKuOVA4QCEQvF2=	M{Lzb3NCVkeHUh?=
AN3-CA	NEPTVIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVTJR\|UxRTJ{Lk[wPFQh\|ryP	MYjTRW5ITVJ?
HuO9	NGTKXFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXTzSJdUUUN3ME2yNk44Ozl4IN88US=>	MnO2V2FPT0WU
COLO-800	M2OwfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYnNOY5EUUN3ME2yNk44PjV\|IN88US=>	NVXHOVlRW0GQR1XS
HT-29	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NITqc21KSzVyPUKyMlg5OjNizszN	NXf1SXZwW0GQR1XS
OC-314	M2L2NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MofZTWM2OD1{Mj64PFQ2KM7:TR?=	M33XZXNCVkeHUh?=
G-401	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWPSTWhQUUN3ME2yN{4xPDZ{IN88US=>	NITyVVRUSU6JRWK=
Saos-2	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVjJR\|UxRTJ\|LkWxPFIh\|ryP	MlfLV2FPT0WU
UACC-62	M4TIWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlW0TWM2OD1{Mz61PFM{KM7:TR?=	MX7TRW5ITVJ?
D-247MG	M{m1S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3SzNmlEPTB;MkOuO\|k{QSEQvF2=	M{Dv[3NCVkeHUh?=
COLO-741	NWXQe4E1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NE\YO5RKSzVyPUKzMlk2PjVizszN	MY\TRW5ITVJ?
ES3	NUnPfpFrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVnGXZh[UUN3ME2yOE4xODJ\|IN88US=>	MlrHV2FPT0WU
LNCaP-Clone-FGC	NIHyWnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NELTe\|JKSzVyPUK0MlAzOTFizszN	NX71dYp1W0GQR1XS
SW1710	M1jLSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVXwPGZFUUN3ME2yOE4yPTB4IN88US=>	M3rxO3NCVkeHUh?=
LU-99A	M33UR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVnJR\|UxRTJ2LkG4OFEh\|ryP	MUjTRW5ITVJ?
HOP-92	NWO4U25wT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWXJR\|UxRTJ2LkeyOUDPxE1?	M1HncXNCVkeHUh?=
LS-123	M{\BZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWPzZlRUUUN3ME2yOE46PjF2IN88US=>	NHPZUZlUSU6JRWK=
T84	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF3TSFhKSzVyPUK0Mlk4PjVizszN	NEHTU\|BUSU6JRWK=
HCT-116	NIfC[plIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVzJR\|UxRTJ3LkSxPFYh\|ryP	MlPzV2FPT0WU
M14	MkPZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHHR[GNKSzVyPUK1MlQ1PDdizszN	M131WXNCVkeHUh?=
OCUB-M	MluwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2nqT2lEPTB;MkWuOFQ2PiEQvF2=	MWjTRW5ITVJ?
MKN45	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUjJR\|UxRTJ3Lk[zNVUh\|ryP	Mlv0V2FPT0WU
LCLC-97TM1	M3XFUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVrJR\|UxRTJ3LkeyPFUh\|ryP	MojSV2FPT0WU
RVH-421	MlG5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mk\STWM2OD1{NT64NVYyKM7:TR?=	NGLZW3JUSU6JRWK=
NKS-81-FD	MlvhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2ewOGlEPTB;MkWuPVAzOSEQvF2=	MVPTRW5ITVJ?
NCI-H596	NInoWoRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIPSO3RKSzVyPUK2MlA1QDdizszN	NV\0U2ZxW0GQR1XS
GB-1	MlfRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHO5XJpKSzVyPUK2MlE5PzlizszN	MoPzV2FPT0WU
ZR-75-30	NV\tfWdMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmrYTWM2OD1{Nj6yNlk4KM7:TR?=	NVjyVIViW0GQR1XS
U-2-OS	NHXKR5NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYrJR\|UxRTJ4LkO3OVch\|ryP	MYTTRW5ITVJ?
HuP-T3	NUTpc2J6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2PB[2lEPTB;Mk[uOlExOiEQvF2=	NHHVO4pUSU6JRWK=
MOLT-16	NYmwTVVvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYPVT45zUUN3ME2yOk43OTZ4IN88US=>	NEn4dZhUSU6JRWK=
U-87-MG	NYf4Rm9VT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1TkfWlEPTB;Mk[uO\|Q{QCEQvF2=	Moi0V2FPT0WU
8505C	NH7xZXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmG0TWM2OD1{Nj65NVI3KM7:TR?=	NFiz[pdUSU6JRWK=
SK-MEL-3	NIXnfJZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXnMc4s{UUN3ME2yOk46QDJ6IN88US=>	MX7TRW5ITVJ?
COLO-824	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mk\5TWM2OD1{Nz6yNVk2KM7:TR?=	M{C0cXNCVkeHUh?=
EW-1	NIDKfldIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYrJR\|UxRTJ5LkO1OVQh\|ryP	NHvqT2pUSU6JRWK=
UACC-257	NGrQ[WZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlXNTWM2OD1{Nz6zPFA1KM7:TR?=	NFXQcVZUSU6JRWK=
Hs-578-T	NF2wPWNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFLIfnJKSzVyPUK3MlUzQTlizszN	NYrRfnoyW0GQR1XS
UACC-893	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYDJR\|UxRTJ5Lk[2N\|Eh\|ryP	NITXfVNUSU6JRWK=
MHH-NB-11	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGTJVJZKSzVyPUK3MlgxODdizszN	NGG4XIdUSU6JRWK=
KYSE-410	M4TufGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGG4SnJKSzVyPUK4MlI4PzlizszN	MlPYV2FPT0WU
SF126	NWr0Xpl6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHfPXFlKSzVyPUK4Mlc1OzVizszN	NEX4XXFUSU6JRWK=
HT-144	NGjXN3JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFnKVZNKSzVyPUK5MlM{PjJizszN	MkLmV2FPT0WU
SW1573	NYXDOVFDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3TNcWlEPTB;MkmuN\|UxQSEQvF2=	NEfSZolUSU6JRWK=
SW620	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmHjTWM2OD1{OT6zOlQyKM7:TR?=	NEfDbXFUSU6JRWK=
SCH	NIfiR5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGXieo1KSzVyPUK5Mlg5OzFizszN	NYPybYE6W0GQR1XS
EW-22	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2DPVWlEPTB;M{CuNVk3QSEQvF2=	MXzTRW5ITVJ?
H4	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGHXTpZKSzVyPUOwMlQ3PTRizszN	NFL3WWxUSU6JRWK=
CAS-1	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIXYNZZKSzVyPUOwMlc5PTlizszN	NVT4R\|RCW0GQR1XS
MG-63	NF7q[HpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHqzNlBKSzVyPUOwMlg1PzhizszN	M3XMeHNCVkeHUh?=
MDA-MB-415	M{Pob2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF3ufZlKSzVyPUOxMlE4PTNizszN	NWTR[3h6W0GQR1XS
NCI-H1395	NYT4Tm1lT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHXrb4tKSzVyPUOxMlI{OjhizszN	MnS3V2FPT0WU
Ca-Ski	Mn\aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmnLTWM2OD1\|MT6zNVc4KM7:TR?=	MXnTRW5ITVJ?
BxPC-3	NIGzNVBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVzYRmlUUUN3ME2zNU4{PzJ7IN88US=>	NE\4[G9USU6JRWK=
A3-KAW	NHO2SoxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoPsTWM2OD1\|MT60OFcyKM7:TR?=	NGjCVYRUSU6JRWK=
T-24	M2jVXGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV22SG9GUUN3ME2zNU44OzZ{IN88US=>	M1XyXHNCVkeHUh?=
NCI-H2029	NHfzNnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3PWOmlEPTB;M{GuO\|c3PSEQvF2=	NYGwPJp{W0GQR1XS
YAPC	M2DJ[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NW\Zb4U6UUN3ME2zNk4xPDB5IN88US=>	MYrTRW5ITVJ?
SK-MEL-2	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEX6UXlKSzVyPUOyMlA2OiEQvF2=	MVvTRW5ITVJ?
LS-513	Ml7yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mm\LTWM2OD1\|Mj6xNVg4KM7:TR?=	MXPTRW5ITVJ?
AsPC-1	M3qzdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXvJR\|UxRTN{LkO2NFUh\|ryP	NEniVo9USU6JRWK=
KYSE-150	NUP6b5FmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{nQWmlEPTB;M{KuN\|c4OyEQvF2=	MXXTRW5ITVJ?
NCI-H520	NH;oNmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUDJR\|UxRTN{LkS0PFIh\|ryP	Mn;kV2FPT0WU
JEG-3	NVH0WVg4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFzrXZFKSzVyPUOzMlA6PzFizszN	M136XXNCVkeHUh?=
GMS-10	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlfzTWM2OD1\|Mz6zNFA1KM7:TR?=	M135OXNCVkeHUh?=
HT-1080	M2jaUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmrZTWM2OD1\|Mz6zPUDPxE1?	M4HEVXNCVkeHUh?=
NCI-H1651	NGiwSIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1XaPWlEPTB;M{OuN\|k3KM7:TR?=	MkTHV2FPT0WU
NCI-H2122	M3TVNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXGzcmZYUUN3ME2zN{42PTd2IN88US=>	MlHMV2FPT0WU
ES5	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXzJR\|UxRTN\|LkeyPVIh\|ryP	M1\tcXNCVkeHUh?=
8305C	Mn3MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWK4cYlYUUN3ME2zN{46QTN5IN88US=>	MXHTRW5ITVJ?
KM12	M3rMZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnPFTWM2OD1\|ND6wOFc5KM7:TR?=	NUPjSFFiW0GQR1XS
HCT-15	NHPFOmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWjWfXVQUUN3ME2zOE4yOjdizszN	NHPkNJBUSU6JRWK=
OVCAR-5	Mn3yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MW\JR\|UxRTN2LkKxPFIh\|ryP	NVnjOpQ4W0GQR1XS
NCI-H2291	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFfKVFFKSzVyPUO0MlI1PzJizszN	NXXpc2dIW0GQR1XS
CP50-MEL-B	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV;JR\|UxRTN2Lk[1PVIh\|ryP	MlzVV2FPT0WU
C-33-A	M{\kTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFrhd5lKSzVyPUO0MlY5PTdizszN	NFi3eZVUSU6JRWK=
NCI-H2452	NFfPdZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXjVdGFMUUN3ME2zOE44QDh{IN88US=>	NWP4cotUW0GQR1XS
MDA-MB-157	MmTYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFP5UWlKSzVyPUO0MlgyQTNizszN	M{DnXXNCVkeHUh?=
LN-405	NIK2UFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmqzTWM2OD1\|NT60N\|A5KM7:TR?=	MWTTRW5ITVJ?
MDA-MB-231	M3qzTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mnz6TWM2OD1\|NT61NFU1KM7:TR?=	NIL6S\|FUSU6JRWK=
EW-24	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlXnTWM2OD1\|NT62N\|M2KM7:TR?=	MY\TRW5ITVJ?
MKN28	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGL1[WVKSzVyPUO1MlgzOzZizszN	Mn;zV2FPT0WU
KINGS-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVvDNm9RUUN3ME2zOU45PDN2IN88US=>	NX[xcnBGW0GQR1XS
LC-2-ad	M4OySmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWHqbZhxUUN3ME2zOk43QTlizszN	NEjTNJFUSU6JRWK=
IGR-1	NHLQXHdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX7JR\|UxRTN4LkewO\|Uh\|ryP	MYrTRW5ITVJ?
SW626	NGrFNYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXXqXJNuUUN3ME2zO{4xPDF5IN88US=>	M1Kz[3NCVkeHUh?=
ONS-76	M1T0SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYPJR\|UxRTN5LkGzNFkh\|ryP	MlnvV2FPT0WU
T98G	NV7iU491T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFX5S2xKSzVyPUO3Mlg3OzVizszN	MX7TRW5ITVJ?
NB14	NGHsTGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1TzfGlEPTB;M{iuOFU1PCEQvF2=	NUjoTWhvW0GQR1XS
D-423MG	M2rBcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2PRbGlEPTB;M{iuOFg3QSEQvF2=	Mlf4V2FPT0WU
NCI-H510A	Mln4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVf0[3pUUUN3ME2zPE43PDVzIN88US=>	NHO5WoFUSU6JRWK=
NMC-G1	MlPOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3fyTmlEPTB;M{iuO\|IzOiEQvF2=	NFHDbZhUSU6JRWK=
SW948	MlexS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlfZTWM2OD1\|OD64PVQ6KM7:TR?=	MmjPV2FPT0WU
MFM-223	NEmwU4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NY[1VG5xUUN3ME2zPE46PDNzIN88US=>	M2HmSnNCVkeHUh?=
PAN1	NUnVfFllT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUPJR\|UxRTN6Lkm5NVkh\|ryP	MnvaV2FPT0WU
MZ7-mel	MoOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml;4TWM2OD1\|OT6xNVk6KM7:TR?=	NVjrbnpQW0GQR1XS
COLO-679	M3TrPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYPJR\|UxRTN7Lkm3NFgh\|ryP	M{DMWHNCVkeHUh?=
SW872	M{PPdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUjJR\|UxRTRyLkKwN\|Eh\|ryP	NIfvRplUSU6JRWK=
HT-1197	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M17Bb2lEPTB;NECuNlg3QSEQvF2=	NY\CUHVQW0GQR1XS
ES6	M1LlNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4rxNGlEPTB;NECuOFU2OiEQvF2=	MWDTRW5ITVJ?
SNU-387	NY\3NW06T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXjJR\|UxRTRyLkiyN\|gh\|ryP	M4TVSHNCVkeHUh?=
T47D	NV;PcY0xT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUHJR\|UxRTRzLkCxPVIh\|ryP	NFfEdWtUSU6JRWK=
G-402	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXHJR\|UxRTRzLkC4NFkh\|ryP	MWTTRW5ITVJ?
MZ1-PC	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnLrTWM2OD12MT64NUDPxE1?	NV:zR2tTW0GQR1XS
SW1417	NETiXnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEDCdFNKSzVyPUSyMlMxOyEQvF2=	Ml7EV2FPT0WU
RERF-LC-MS	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3LDUmlEPTB;NEKuOVA5PyEQvF2=	NUXXXlZQW0GQR1XS
SF539	MmHuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGm0VFJKSzVyPUSyMlU2OjlizszN	M{XoN3NCVkeHUh?=
ESS-1	MkHJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXjJR\|UxRTR\|LkW1OVgh\|ryP	MXTTRW5ITVJ?
RO82-W-1	M1T6NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmP4TWM2OD12Mz62NVU{KM7:TR?=	NYTKfXNJW0GQR1XS
S-117	NEnH[FFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXHTNY1CUUN3ME20N{43QTV6IN88US=>	NVrJXFlNW0GQR1XS
SW756	NX3Peo96T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWnJR\|UxRTR\|LkiyOFIh\|ryP	MlXpV2FPT0WU
CP66-MEL	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX3JR\|UxRTR3LkexOFMh\|ryP	NYewTIV5W0GQR1XS
H-EMC-SS	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV3JR\|UxRTR3Lke2PVMh\|ryP	NWT3OG9tW0GQR1XS
NCI-H2052	M2LMNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXzJR\|UxRTR3LkmwNlch\|ryP	MlzYV2FPT0WU
SW684	MlHrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MU\JR\|UxRTR5LkCwPFEh\|ryP	MlnpV2FPT0WU
HCC1569	M1vYNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NH61cGVKSzVyPUS3MlE3PThizszN	M3ThNHNCVkeHUh?=
KGN	M3LVXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NY\KfGpxUUN3ME20O{4{OzFzIN88US=>	MnzaV2FPT0WU
LCLC-103H	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Ml7NTWM2OD12Nz60OFA1KM7:TR?=	MYjTRW5ITVJ?
SW780	MkTXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUPJR\|UxRTR5Lk[zOVEh\|ryP	NXvnZo5CW0GQR1XS
NCI-H1703	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFO5cXlKSzVyPUS4MlM{PTJizszN	MXvTRW5ITVJ?
HCC1395	Ml\oS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NELLSGpKSzVyPUS4Mlc1OzJizszN	MmLlV2FPT0WU

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	phospho-EGFR / phospho-ERK / phospho-SRC / phospho-AKT; PubMed: 22586683 &n

研究领域